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This project assessed the cost effectiveness of two brief interventions offered in emergency 
departments in the Western Cape Province of South Africa. It was part of the STRIVE 
(Substance use and Trauma Intervention) study whose aim was to decrease substance use and 
its associated harms among South Africans attending emergency services in the Western 
Cape Province. The two brief interventions were Motivational Interviewing (MI) and a 
combined intervention of MI and Problem Solving Therapy (PST). These were delivered by 
peer counsellors who were trained specifically to do this exercise. To assess the financial 
feasibility of the intervention, the current study was conducted. Outcomes and costs were 
estimated from the main STRIVE study. The outcomes of interest were reduction in patient’s 
ASSIST (Alcohol, Smoking and Substance Involvement Screening Test) score, depressive 
symptoms and verbal arguments. The main costs analysed were the overhead costs of 
emergency department visits, the direct costs of the interventions and the costs of screening. 
A decision tree model was used to assess the cost-effectiveness of the interventions. The cost 
of using the peer counsellors instead of trained clinical psychologists (task-shifting) was also 
analysed.   
The results of the study showed that both interventions were more costly and more effective 
than the status-quo of no intervention. The combined intervention of MI and PST was more 
costly (R 1093.36 per patient) than the MI only intervention (R779.89 per patient). It was also 
more effective in reducing a patient’s ASSIST score and depressive symptoms, leading to an 
incremental cost-effectiveness ratio (ICER) of R340.66 per mean reduction in patient’s 
ASSIST score and R133.46 per mean reduction in depression score. The MI only intervention 
was eliminated through extended dominance with respect to these outcome measures.  
iv 
 
The MI only intervention on the other hand was more effective in reducing verbal arguments 
and had an ICER of R3500.48 per patient. For this outcome measure, the combined 
intervention of MI with PST was eliminated through absolute dominance because it was more 
costly and less effective.  The cost of training and employing peer counsellors to screen and 
offer the interventions was found to be R112 390 per peer counsellor over the study period of 
nine months. 
Two conclusions can be drawn from the study. Firstly, it can be inferred from the study that 
screening and delivery of brief interventions in the emergency departments has the potential 
to be cost-effective.  Secondly, it is feasible to train peer counsellor’s to screen and 
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Background 
Substance use refers to the use of psychoactive drugs or substances which act in the brain to 
alter the user’s ‘consciousness, mood or thinking process’ (World Health Organization, 2004: 
p.1). Examples of such substances include alcohol, mandrax, sedative-hypnotics (example
benzodiazepines), opioids (example heroin), petrol, glue, cocaine, amphetamines, caffeine, 
nicotine, cannabis, ecstasy, etc. (Baumann, 2007). The use of these substances has different 
effects on the user depending on what substance is used, the intended aim of the user and the 
pattern of use (Baumann, 2007). The excessive or wrongful use of substances other than what 
they are intended for is described as substance misuse. Hazardous/risky substance use refers 
to misusing substances in a way that elevates the user’s personal risk of the negative effects 
of the substance. Harmful substance use is when a user misuses substances in a way that 
causes actual harm to the user’s mental or physical health (Baumann, 2007). The continual 
use and/or misuse of psychoactive substances is known to have long term harmful effects like 
‘dependence syndrome – a cluster of behavioural, cognitive, and physiological phenomena 
that develop after repeated substance-use and that typically include a strong desire to take the 
drug, difficulties in controlling its use, persisting in its use despite harmful consequences, a 
higher priority given to drug-use than to other activities and obligations, increased tolerance, 
and sometimes a physical withdrawal state’ (World Health Organisation [WHO], n.d.: p.1).  
Global/Public Health problems of substance use 
Substance use disorders account for a number of public and global health problems. Alcohol 
and illicit drugs are reported to be the cause of death of over 350,000 and 40,000 people 
respectively per year globally (World Health Organization, 2010). 5.4% of the world’s annual 
burden of disease can be associated with alcohol and illicit drug use, leading to problems 
such as cardiovascular diseases, HIV, Hepatitis C, cancers and injuries (World Health 
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Organization, 2010). The prevalence of HIV among injecting-drug users is reported to be 
about 20%, hepatitis C is about 46.7% whilst that for hepatitis B is about 14.6% globally 
(UNODC, 2012). Cannabis and amphetamine-type stimulants (ATS) are reported to be the 
‘most-widely’ used substances globally (UNODC, 2012: p.1).  
Substance use problem in South Africa 
The lifetime prevalence of substance use disorder in South Africa is estimated to be about 
13.3% with an estimated life time risk of about 17.5%, and this is among the highest in the 
world (Herman et al, 2009). The Western Cape Province is reported to have the highest 
lifetime prevalence rate of substance use disorder among all the nine provinces in the country 
with a rate of 20.6, which is higher than the national rate of 13.3 (Herman et al, 2009). The 
contribution of alcohol-related harm to total deaths and DALYs (Disability Adjusted Life 
Years) in the country in the year 2000 was 7.1% (37000 deaths) and 7.0% (1.1 million 
DALYs) respectively (Schneider et al, 2007).  63.1% of the alcohol related DALYs were as a 
result of injuries; 39% and 14.3% of these injuries were as a result of interpersonal violence 
and road traffic accidents respectively (Schneider et al, 2007).  
Alcohol is the most commonly used substance in South Africa with a lifetime prevalence of 
11.4% (Herman et al, 2009). Other substances used in the country include  dagga (cannabis), 
tobacco, glue, cocaine, medication (prescribed drugs), heroin, crystal methamphetamine (tik) 
mandrax, methcathinone ‘cat’ and ‘sugar’ or ‘sugars’ which is a combination of heroin and 
cocaine or other stimulants along with various other substances (Baumann, 2007: p.291). Tik 
is mostly used in the Western Cape Province although used in smaller quantities in the 
Northern Cape Province (Baumann, 2007; Pasche & Myers, 2012). 
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Substance use disorder, interpersonal violence, depression and injury 
The high prevalence of interpersonal violence and injuries in South Africa has been reported 
to be associated with the high rates of substance use in the country (Norman et al, 2007; 
Schneider et al, 2007). Based on this, it has been suggested that a great proportion of injuries 
and mortality in South Africa could be averted if alcohol misuse is eliminated or at least 
controlled (Parry et al, 1996). Substance use has been reported to cause changes in the 
biological functioning of the user and this increases aggressive behaviour (Atkinson et al, 
2009). Alcohol users for instance are reported to be more likely to engage in activities and 
situations that increase their vulnerability to accidental injuries (Cherpitel, 1999). An 
association between depression and substance use disorder has been reported in different 
studies. A review of studies on the subject has reported that there is a likely causal 
relationship between depression and alcohol use disorder (Swendsen & Merikangas, 2000). A 
relationship has also been reported between heavy cannabis use and depression in another 
review (Degenhardt et al, 2003). 
Substance use and the Emergency department 
Injured patients are mostly treated in emergency departments and these injuries are usually as 
a result of substance use of some kind (Hungerford, 2005a; Hungerford, 2005b). In South 
Africa, it is reported that patients seeking treatment in emergency departments are mostly 
those with injuries resulting from interpersonal violence (Brysiewicz, 2001). There is also a 
high likelihood for injured patients seeking treatment in emergency departments to test 
positive for alcohol use (Parry et al, 2002). 
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Screening and Interventions for substance use 
Interventions available for substance users include brief interventions and treatment services 
(Kumar & Malhotra, 2000). Patients are screened first to determine their level of risk or 
extent of substance use before they are offered interventions. In addition to helping to know 
which type of intervention to offer to users, screening also helps patients to become aware of 
the extent of their substance use and also to make decisions about their substance use by 
means of the feedback they receive after screening (Henry-Edwards et al, 2003). It should be 
noted that screening tools are used to assess levels of risk and are not used as a psychiatric 
diagnosis. 
There are a number of effective screening tools available. These are mainly biological 
markers and self-report screening tools. 
Biological markers 
Biological markers are ‘biochemical substances in the body that can indicate the presence or 
progress of a condition or any genetic predisposition toward it’ (Peterson, 2004: p.30). 
Semen, urine, saliva, blood, ear wax and hair are biological samples commonly tested for the 
presence of psychoactive substances in the body. The choice of biological sample usually 
depends on the type of psychoactive substance being tested for, the setting and the time-
frame. Whilst some samples are more reliable in detecting substances presently active in the 
body (blood and saliva), others like urine and hair help to detect substances used over a 
longer period of time (Wolff, 2003). The process of testing usually involves taking the body 
sample to the laboratory to be screened for the presence of psychoactive substances using 
immunoassay or chromatography techniques. Examples of biological markers commonly 
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used for alcohol screening include mean corpuscular volume (MCV), gamma-glutamyl 
transferase (GGT) and carbohydrate-deficient transferrin (CDT) (Peterson, 2004). 
Self-Report 
Self-Report tests or tools for screening for substance use include the AUDIT (Alcohol Use 
Disorders Identification Test), ASSIST (Alcohol, Smoking and Substance Involvement 
Screening Test), CAGE (Cut down, Annoyed, Guilty, Eye opener), CRAFFT, DAST (Drug 
Abuse Severity Test), GAIN (Global Appraisal of Individual Needs), S-MAST (Short 
Michigan Alcohol Screening Test), TWEAK (Tolerance, Worried, Eye opener, Amnesia, Cut 
down), RAPS – or RAPS 4 – (Rapid Alcohol Problems Screen), T-ACE (Tolerance, 
Annoyed, Cut down, Eye opener) and POSIT (Problem Oriented Screening Instrument for 
Teenagers) (American Public Health Association and Education Development Center, Inc., 
2008). Most of these tools are used for screening for alcohol use. AUDIT, DAST and 
ASSIST are reported to be the most commonly used (Office of alcoholism and substance 
abuse services, 2012). ASSIST was used for screening in the STRIVE study. 
Although biological markers are reported to be relatively less biased compared to self-
reporting of substance use (Schwan et al, 2004), there are some limitations to this option 
which makes it less attractive to use. The way samples are collected and supervised is 
important and to some extent, these pose some limitations to the use of biological markers. 
Contamination and dilution of samples must be completely avoided as these can affect the 
results of the tests (Wolff, 2003). Biological markers are also often expensive (Darke, 1998)  
and may not be best for resource limited countries. Research also suggests that none of the 
methods currently being used is perfect (Peterson, 2004)   and thus not any more reliable than 
measures of self-report. A review of literature has also shown that self-reporting for 
 
6 | P a g e  
 
substance use is accurate and effective enough to help identify the pattern and extent of 
substance use and related problems (Darke, 1998).  
Brief Interventions  
Brief interventions are ‘a group of cost-effective and time efficient strategies’ aimed at 
minimising substance use and/or associated harm (Kumar & Malhotra, 2000: p.172). They 
involve offering advice or counselling about the substances and their harmful effects to users. 
Motivational interviewing (MI) is a brief intervention mostly offered to substance users, 
especially those at moderate risk of substance use problems and sometimes as an initial 
intervention for those with dependence problems to enable them to adhere to treatment 
services (Henry-Edwards et al, 2003;	   Kumar	   &	   Malhotra,	   2000). It is a counselling 
technique that focuses on the patient’s initiative for change instead of directives from the 
counsellor (Miller, 1996). The aim of brief intervention is to help substance users 
comprehend the risks associated with their substance use, motivate them to minimise or quit 
the use of such substances and also to seek specialist care for their problem where necessary. 
They are also aimed at helping to minimise resistance among patients and also aid in making 
behaviour change decisions (Henry-Edwards et al, 2003). Brief interventions can be as short 
as a five minutes advice to a user about the harmful effects of the substances or as long as a 
one hour counselling session with the user. During these interventions self-help hand-outs 
and other materials meant to help users are also provided. In some cases the intervention goes 
beyond just advice and information provision to more rigorous therapy sessions. These 
however do not go beyond six sessions (Babor & Kadden, 2005; Henry-Edwards et al, 2003). 
Brief interventions have been proven to be effective in reducing substance use in different 
settings in the world (Sorsdahl et al, 2012). Furthermore, it has been proven that providing 
these interventions in health care facilities, especially in emergency departments, can help to 
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decrease substance use among patients. This can further minimise repeated injuries, re-
admissions into emergency departments and also improve the health of patients (Gentilello et 
al, 1999; Hungerford, 2005a; Hungerford, 2005b). 
Treatment for substance use 
Besides offering brief interventions, there are treatments for those with dependence problems. 
Treatments for these patients involve offering ‘specialised medical, psychiatric and 
psychosocial services’ (Temmingh & Myers, 2012: p.290). These treatments are aimed at 
helping users to abstain from the use of psychoactive substances or at least minimise their 
use. They are also aimed at reversing the negative consequence of substance use on their 
health and social life (Baumann, 2007).  Treatments involve detoxification and are usually 
offered in both out-patient and in-patient departments. Patients usually need rehabilitation 
and/or medications to help ‘prevent relapse’ (Baumann, 2007: p.305). Support groups like 
AA (Alcoholic Anonymous), NA (Narcotics Anonymous) and CAD (Christelike 
Afhanklikheidsdiens) are also necessary to help patients after rehabilitation. Unlike brief 
interventions, this kind of intervention requires the use of specialists and usually extends for 
months and in some cases, years (Baumann, 2007; Kumar & Malhotra, 2000). 
Limited mental health services/workers and task-shifting 
Despite the high prevalence of substance use disorders and its associated negative effects, the 
availability of treatment services in South Africa is limited. This has been influenced by 
many socio-political factors, especially during the period of apartheid (Temmingh & Myers, 
2012). Even though the situation seems to have improved in post-apartheid South Africa, the 
problem still exists, especially for the most vulnerable, the majority of whom live in 
disadvantaged communities. Available treatment facilities are expensive, especially for those 
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without medical aid and state funded ones are also insufficient (Myers et al, 2010; Temmingh 
& Myers, 2012)  
Given this problem and the high prevalence of substance use problems in South Africa, brief 
interventions for at risk users before they become dependent and require treatment services 
can be a good intervention option. In addition to being less costly and relatively effective in 
reducing problematic and hazardous substance use, brief interventions can also be used as 
health promotion and substance use prevention tools in health care settings. Although brief 
interventions cannot be used to treat people with dependence problems, they can be used to 
motivate such patients to accept specialist care (Henry-Edwards et al, 2003). 
There is still the issue of shortage of mental health workers and professionals even with the 
administration of brief interventions. In light of this problem and the increasing demand for 
mental health workers and professionals, task-shifting to lesser trained personnel has been 
recommended as a means of bridging the gap (Petersen et al, 2012).Task-shifting has been 
described as a potential tactic that can be employed to help address the challenge of shortage 
of health care workforce (Fulton et al, 2011).  Unlike treatment services, specialists are not 
needed for the administration of brief intervention. They can be administered by health care 
professionals with limited training (Kumar & Malhotra, 2000). In the South African setting, a 
pilot study has reported that the use of peer counsellors for screening and brief interventions 
for substance use in emergency departments in Cape Town is feasible with marginal added 
costs (Myers et al., 2012).  The study also showed that the use of these peer counsellors does 
not interrupt the usual flow of health care services in these emergency departments. In 
addition, their presence will also help to prevent the extra work load that screening and brief 
intervention will otherwise add to the existing workload in these emergency departments 
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(Myers et al., 2012). Task-shifting is especially important in resource limited countries where 
the demand for mental health workers is not adequately matched with their supply. 
Studies on the effectiveness as well as the cost-effectiveness of screening and brief 
interventions in the emergency departments are essential to inform decision making. It is also 
important that studies investigate the type of brief intervention that would be most suitable 
and effective to implement in such settings given the work environment and how busy it can 
be. An example of such a study is the STRIVE study (described below) which this cost-
effectiveness analysis study forms a part of.  
The STRIVE study 
The aim of the STRIVE  study was to decrease substance use and its associated harms among 
South Africans attending emergency services by testing two brief, evidence-based 
interventions: motivational interviewing (MI) and a combination of motivational interviewing 
and Problem Solving Therapy (PST). These interventions were delivered by peer counsellors 
to risky substance users among adults attending emergency departments in the Western Cape 
Province of South Africa. The purpose of the study was to help address the gaps in current 
service delivery. Three study sites, Khayelitsha district hospital, Khayelitsha site B 
community health clinic and the Elsies River community health clinic, were used. Lay 
counsellors (not originally part of the routine health staff in the facilities) were recruited and 
trained to screen and offer the interventions to the patients in the facilities. To ensure that 
these counsellors were delivering the interventions appropriately, a clinical psychologist was 
employed to undertake fidelity checks with the counsellors every two weeks, and to ensure 
counsellors were coping with the stressful work environment of the emergency departments. 
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Consent for screening was taken from adult patients attending the emergency departments in 
the study health facilities. Those not in the position to give consent such as patients with 
severe head trauma or confusion were excluded from the study. Consenting patients were 
screened for substance use using the ASSIST screening tool. The advantage of the ASSIST 
over other screening tools, is that it screens for harmful use of all psychoactive substances 
from alcohol and tobacco use to the use of a wide range of other illicit drugs considered in 
this study – alcohol, cannabis, cocaine, amphetamine type stimulants (mostly tik), inhalants, 
sedatives or sleeping pills, hallucinogens and opioids. It also helps to detect patients who use 
or depend on one or more of the substances and it can also be used across different age 
groups unlike other screening tools. The ASSIST screening tool has been proven to be 
effective in different countries and across different languages (Henry-Edwards et al, 2003). 
Depending on patients’ scores on the ASSIST, patients were classified as being at low risk, 
moderate risk or high risk of substance use. Patients who scored between 0-10 for alcohol use 
and 0-3 for each of the other substances were classified as being at low risk. Those who 
scored between 11-26 for alcohol use and 4-26 for each of other substances were classified as 
being at moderate risk and those who scored above 27 for each of the substances were 
classified as being at high risk (Humeniuk et al, 2010).  
Patients classified as being at moderate risk of substance use were invited to join the study 
and those classified as being at low risk were excluded from the study. Those classified as 
being at high risk were invited to participate in the study, but were also referred for specialist 
care. Participants who agreed to be part of the study were randomly allocated to either a 
psycho-educational control group or an intervention group (either an MI only group or a 
combination of MI and PST group).  A baseline questionnaire on self-reported alcohol and 
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other drug use, health and other risk behaviours and problem-solving styles was then 
completed by the patients.  
All patients randomised into the intervention group received the MI which lasted about 30 
minutes on the average for each patient. Those in the MI only intervention group received 
just this. Patients in the combination of MI and PST intervention group received in addition 
to the initial MI, four sessions of PST. The first PST session lasted between 45 to 60 minutes 
per patient and the rest of the other three sessions lasted between 35 to 50 minutes per patient. 
Those in the control group, like all others in the study, received a self-help brochure 
describing the effects of alcohol and other drug use, thus the name, psycho-educational 
control group.  
PST helps patients to develop attitudes and skills towards problem-solving (D’Zurilla & 
Nezu, 2010). Patients are usually offered alternative ways of solving their problem and based 
on these they are expected to make a choice of the most effective alternative they can apply 
to their problem (D'Zurilla & Goldfried, 1971). Through this intervention, patients are able to 
gain self-control over their problem and are also able to maintain their change in behaviour. 
PST has been shown to help patients to prevent relapse (D’Zurilla & Nezu, 2010). 
At the three month follow-up, participants in both the control and the intervention groups 
were re-administered with base-line questionnaires. Effectiveness of the interventions with 
respect to the outcomes of interest was assessed by comparing before and after base line 
questionnaires. The outcomes of interest were functional and dysfunctional, reduction in 
problematic substance use, individual’s depression level, substance use related injury, and 
substance use related violence. For ethical reasons, control participants who remained at high 
risk for substance use problems were referred to specialised service providers.   
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Purpose of the cost-effectiveness analysis  
The purpose of this study is to compare the costs and effectiveness of the two brief 
interventions tested in the STRIVE study described above in relation to a do-nothing status- 
quo.  
Justification of the study 
The justification for carrying out this research is to help policy makers to decide which brief 
intervention for substance disorder will be more cost-effective to implement in emergency 
departments.  
Why cost-effectiveness analysis? 
Resources are usually scarce and getting funds to support the implementation of brief 
interventions in emergency departments has been reported to be relatively difficult compared 
to accessing funds for similar activities in primary care facilities (Hungerford,  2005a). Policy 
makers and funders therefore need adequate information including information on costs to 
guide their decisions to fund the implementation of such activities in emergency departments.  
To be able to provide such information to guide decision making, a cost-effectiveness 
analysis of the alternative brief interventions as provided in the emergency departments is 
needed. It helps to compare the costs as well as the effectiveness of each of the interventions 
against each other.  
Cost-effectiveness analysis is one of the different methods of economic evaluation which 
include cost analysis, cost utility analysis (CUA) and cost-benefit analysis (CBA), even 
though cost-analysis is not considered a full economic evaluation method (Drummond et al, 
2005).  All these methods measure and value costs in monetary terms but differ in the way 
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outcomes are evaluated (Luce & Simpson, 1995). For instance, Cost-analysis does not 
evaluate outcomes of interventions. It only evaluates costs. CBA measures and values both 
costs and outcomes in monetary terms. CUA, which is considered a broader form of CEA, 
values outcomes in terms of utilities attached to the outcomes derived from the interventions 
(e.g. QALYs, DALYs) (Drummond et al, 2005). CEA measures and compares costs and 
effectiveness of alternative interventions that have the same outcome measure. The costs and 
the rate at which the different alternatives achieve the outcome of interest may however 
differ. It values outcomes in their natural units (e.g. life years saved, number of sick days 
averted). This makes it more feasible for this study than the other methods of economic 
evaluation because outcomes are measured and valued in terms of reduction in patient’s 
ASSIST score, depression and verbal arguments.  
Like all the other methods of economic evaluation, CEA can be conducted from three main 
perspectives – provider perspective (which considers costs only incurred by the provider of 
the intervention as a result of the intervention), patient perspective (considers cost incurred by 
the patient and relatives as a result of the intervention) and societal perspective (considers 
both costs to patients and the provider). Societal perspective is the broadest perspective. In 
cost-effectiveness analysis, decisions are made between alternative interventions by 
estimating the incremental cost-effectiveness ratios (ICERs) of the interventions. ICERs are 
estimated as the ratio of the difference in costs and effectiveness of the competing 
interventions as illustrated in equations (1) and (2) below. There are not always competing 
interventions. Sometimes new interventions are compared to a status quo which may be a no 
intervention situation. 
ICERYX=ΔC/ΔE……………………………………. (1) 
ΔC=CY – CX; ΔE= EY – EX…………………………… (2) 
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Where CY is the cost of intervention Y (the new intervention) and EY is its effectiveness; CX 
and EX are the costs and effectiveness of intervention X (the old intervention or status-quo). 
The results of CEA are expressed as cost/outcome (e.g. cost/life year saved or cost/reduction 
in substance use). A sensitivity analysis is usually conducted to address the issue of 
uncertainty which can affect the findings of the analysis (Briggs, 1995). Such uncertainties 
may arise from the way data was sampled, choice of analytic methods, data extrapolation and 
generalizability of study findings. Sensitivity analysis helps to generalise the results of the 
analysis (Briggs, 1995).  
Aim and objectives of the study 
Research has suggested that brief interventions can be administered within public health 
facilities in South Africa with little demand for additional resources and minimal burden on 
health workers, and that they are effective in helping to reduce substance-use (Temmingh & 
Myers, 2012). However, no comprehensive assessment of the costs and effects has been 
undertaken. Given this need, the main aim of this study is to assess the cost-effectiveness of 
providing brief interventions for adult substance users attending emergency departments in a 
South African setting.  
The objectives of the study are as follows: 
1. To calculate the provider cost of emergency department visit. 
2. To assess the provider cost of screening patients for alcohol and drug use in 
emergency department. 
3. To assess the societal costs of providing either a short ASSIST-linked Brief 
Intervention (MI) or a combination of MI and PST to substance users in emergency 
departments. 
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4. To assess the cost-effectiveness of the interventions in comparison to a no 
intervention status quo. 
5. To do a cost analysis of task shifting 
Methods 
Study Design 
Outcomes and costs are estimated from the STRIVE study. Both the ingredients and step 
down methods are used to calculate the economic cost of interventions. Cost-effectiveness is 
assessed from a societal perspective. A decision analytic model is used to assess the cost-
effectiveness of the interventions. Three scenarios are compared; the cost and effectiveness of 
the MI only is compared to that of the status quo of no intervention and the cost and 
effectiveness of the MI with PST intervention is compared to that of the status quo of no 
intervention and then to that of the MI only.  
Study population 
The study population includes patients screened for substance-use at the emergency 
departments of Khayelitsha Site B community health centre, Khayelitsha district hospital and 
Elsies River community clinic. All patients consented to and who were included in the 
STRIVE study discussed above are included in this study.  
Sample size 
Based on the STRIVE study, a sample size of 335 is used for this study. Out of this 335, a 
sample size of 110, 113, and 112 are considered for the control, MI and PST groups 
respectively.  
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Estimation of costs 
The main costs analysed are the overhead cost of emergency department visit, direct cost of 
screening and the interventions from a provider’s perspective and costs to patients for taking 
part in the PST intervention.  
Direct cost of screening and intervention from the provider’s perspective 
These include recurrent costs and capital costs. Recurrent costs are costs incurred on items 
that last for not more than a one year period. For this study they include the cost of salaries of 
counsellors, costs of materials used in the intervention (cost of substance use risk cards, PST 
booklets, substance use fact sheets, pens and clip boards), overheads, cost of fidelity checks 
for the counsellors (costs of clinical psychologists, tapes used, and checking of the tapes). 
Unit costs of all these are calculated from routine data (salaries, overheads etc.) for recurrent 
items sourced from the health facilities through the department of health and the appropriate 
service providers. 
Capital costs are costs incurred on things that last for more than a one year period and they 
include the cost of space and furniture used within the facility and costs of training the 
counsellors. Costs of furniture and space are based on estimated replacement values of these 
items with appropriate annualisation based on useful working life assumptions.  
Telephone costs, vouchers, supervisors used during the study, follow-up and baseline 
assessments (excluding screening) are considered as research costs and are therefore not 
included in the cost estimation. 
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Cost to patients 
This is mainly based on costs incurred by patients as a result of their participation in the 
interventions. These costs include opportunity cost of patient’s time, cost of transportation to 
and from the health facilities for the intervention, opportunity cost of care takers (if any), and 
other non-health care services utilised as a result of their participation in the intervention. 
Opportunity cost of time and care takers are based on time lost from work or any other 
income generating activity. Direct cost of care takers are estimated where these are paid to 
provide their services. These costs are derived from questionnaires administered to 
participants during the STRIVE study. Because the patients in the status quo and the MI 
interventions were already attending the emergency department on account of their substance 
use, it is assumed that no additional patient costs are incurred as a result of being screened or 
having the MI. Those randomised into the PST group however incurred this additional cost 
for their four extra PST sessions because they attended the facility specifically for the 
sessions.  
Estimation of health and non-health related outcomes/effects 
Outcome measures for the study are reduction in substance use (represented by reduction in 
patient’s ASSIST score), depression, and verbal argument over the study period. In the 
STRIVE study, patient’s ASSIST score is assessed with the ASSIST screening tool, 
depression with the Centre for Epidemiological Studies Depression Scale (CES-D) and the 
other outcomes measures with questionnaires designed for the study. The outcome measures 
are calculated for each of the intervention groups as well as the control group. The mean 
point difference for each of these outcomes is derived from the STRIVE study based on the 
base-line and follow-up questionnaires administered to participants during the study. 
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Cost-effectiveness analysis 
A decision tree is used to assess the cost-effectiveness of the interventions. A decision tree is 
a flow chat that illustrates the structure of a problem. It integrates the costs and outcomes of 
the different ways or strategies of dealing with the problem. Decision trees are useful when 
modelling interventions that lead to outcomes in the short-term (example, short term 
screening programs, interventions for acute health care problems, etc.). They are also suitable 
for economic evaluations that involve intermediate outcomes (Karnon & Brown, 1998). They 
are generally useful for modelling problems that involve simple scenarios that are relatively 
less complicated. In this study, the model compares the costs and effectiveness of the 
interventions to that of the status-quo to estimate the incremental costs and effectiveness of 
the interventions. Cost-effectiveness is estimated as the ratio of the incremental costs to the 
incremental effectiveness of the interventions.  
Costing of Task-shifting 
The cost of using peer counsellors instead of clinical psychologists for screening and brief 
interventions is also analysed. This is mainly the costs of peer counsellors’ training and 
fidelity checks. These are derived from the STRIVE study.  
Sensitivity Analysis 
A simple sensitivity analysis is conducted to test the robustness of the study’s findings by 
varying some parameters of the study to test if there will be any major changes in the results 
of the cost-effectiveness analysis. The sensitivity analysis cover the main components of the 
costing analysis and other important parameters identified in the course of the work.  
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Pilot study 
Even though there is no pilot study for this study in particular, a phase one study was 
undertaken by the STRIVE project to assess the relevance and necessity of the programme in 
emergency departments, the feasibility of implementing the intervention, and the potential 
problems and solutions that were likely to occur in the facilities. 
Time schedule 
Data checking and cleaning as well as data analysis and write-up is scheduled between April 
and December 2013. The provider and patients costs were collected earlier as part of the 
STRIVE study.  
Data management and analysis 
Checking and cleaning of data collected from the STRIVE study, the Department of Health 
and other appropriate service providers is done to identify and fix any missing data and 
anomalies. Microsoft Excel is employed for the analysis of the costing data and some aspects 
of the sensitivity analysis and a decision tree model is used for the cost-effectiveness analysis 
and a greater part of the sensitivity analysis. 
Ethical and legal considerations 
There are no ethical or legal issues as a result of conducting this study. The cost-effectiveness 
analysis is part of Project STRIVE which already has ethics approval from the Health 
Sciences Research Ethics Committee of the University of Cape Town. A copy of the ethics 
approval is attached to this document. 
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Reporting of results 
A copy of the results of this study will be submitted to the manager of Project STRIVE. The 
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Introduction 
Screening and brief interventions for substance use disorders are targeted at minimizing 
substance use and related problems. The objectives of this literature review are to: (1) provide 
a theoretical overview of the brief interventions used in this study ( MI and PST) and the 
methods of economic evaluation; (2) provide empirical evidence of the effectiveness of the 
brief interventions; (3) review published literature on economic evaluation of the 
interventions to inform the methodology of the current study and also identify gaps in current 
literature; and (4) to provide an overview of task-shifting as it applies to screening and brief 
interventions.  
Only studies on brief interventions for at-risk substance users were considered in this review. 
Studies on treatments for alcohol and other drug dependence were excluded since that is not 
the focus of the current study. Studies for this review were searched mostly from Google 
scholar, PubMed, EBSCO HOST databases and a manual search of references of other 
studies on the subject.  
The rest of the chapter is in four parts. The first part is focused on the brief interventions, the 
second part is on economic evaluation, the third on task-shifting – basically what it is and its 
application in screening and brief intervention for substance use –lastly the chapter is 
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Theoretical overview of motivational interviewing (MI) 
Motivational interviewing is ‘a directive, client-centred counselling style for eliciting 
behaviour change by helping clients to explore and resolve ambivalence’ (Miller, 1996: 
p.835). It is a style of counselling rather than particular procedures that motivate clients to
change. During motivational interviewing, clients are allowed to come up with steps that can 
help them to change rather than the counsellor trying to find reasons for the clients’ problems 
and dictating to the clients what they can do to help them to change (Miller, 1996).  
According to brief interventions based on a motivational interviewing framework, there are 
six stages of change that can be experienced by a patient during brief interventions. These are 
Pre-contemplation stage – a stage where a patient does not consider the need to change their 
substance use behaviour because they think the positive effects of using the substances 
supersedes the negative effects; Contemplation stage – the stage where the patient compares 
the pros and cons of changing their substance use behaviour against not changing. Patients 
usually have a mixed feeling about the advantages and disadvantages of substance use at this 
stage; Determination or preparation stage – the stage where the patient resolves his mixed 
feeling and makes a decision either to change or not to change; Action stage – the stage 
where the patient takes action towards behavioural change after a decision towards change 
has been made. Here the patient chooses which change approach to go with and actually does 
it; Maintenance stage – the stage where the patient takes steps to maintain the behavioural 
change made in order to avoid relapse; and Termination or Relapse stage – this is the stage 
where the patient either makes a full behavioural change and sustains it thereby terminating 
the intervention or relapses in which situation he has to start the process again (Baumann,  
2007; Kumar & Malhotra, 2000). The process of change is illustrated in figure 1. 
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Figure 1: Illustration of the processes of change during motivational interviewing 
Sources: (Baumann, 2007; Kumar & Malhotra, 2000) 
The following are the guiding principles of motivational interviewing. During motivational 
interviewing, the counsellor or therapist is expected to express empathy, avoid arguments and 
help the patient to weigh the disadvantages of substance use above the advantages. They are 
also expected to ‘roll with resistance’ (Baumann, 2007: p.301; Kumar & Malhotra, 2000: 
p.174) that is, go along with the patient’s resistance to behaviour change or shift the patient’s
focus on resistance or present a new way of viewing the issue under discussion. This 
component is more helpful to patients who refuse to accept any positive idea that can help 
them to make the needed change in their substance use behaviour to get a ‘balanced’ or 
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support patients' self-efficacy by increasing their optimism that they can successfully effect 
change in their substance use behaviour (Baumann, 2007; Kumar & Malhotra, 2000)  
Empirical evidence of the effectiveness of brief MI for substance use 
This section provides evidence of the effectiveness of MI as a brief intervention for substance 
use and some of the common issues arising from these effectiveness studies. Studies included 
here are those conducted in emergency departments with a few useful ones from other 
settings. The outcome measures used to assess the effectiveness of brief interventions for the 
current study are reduction in substance use and related problems – depression and verbal 
arguments. Therefore, only studies with similar outcome measures were considered whilst 
those that considered other intermediate effects were excluded. 
In all, 13 studies were reviewed for this section. Nine of the studies recruited participants 
from emergency departments, one from outpatient clinics, two from the communities and one 
from both emergency departments and out-patient clinics. The subjects of most of the studies 
were adolescents and young adults. This is probably because of the early onset of substance 
use in most situations (Baumann, 2007). Whilst six of the studies concentrated on only 
alcohol, the rest of the studies either looked at other substances or a combination of alcohol 
and other substances. The summary of all the studies included in this review are presented in 
table 1.  
Ten studies showed some form of positive results in favour of the effectiveness of brief 
motivational interviewing (Bernstein et al, 2009;  Bernstein et al, 2005;  Colby et al, 2005;  
Gentilello et al, 1999;  Magill et al, 2009;  McCambridge & Strang, 2004;  Monti et al, 1999;  
Monti et al, 2007;  Stein et al, 2009;  Vasilaki et al, 2006). Compared to no intervention, brief 
MI has been reported to be more effective in reducing alcohol use in emergency departments 
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(Gentilello et al, 1999) as well as cocaine and heroin use (Bernstein et al, 2005). A meta-
analytic review showed that brief MI was more efficacious in reducing alcohol use compared 
to no treatment and other brief interventions like skill-based counselling, directive-
confrontational counselling and cognitive behavioural therapy (Vasilaki et al, 2006). 
Combined with personalised feedback, it has been reported that brief MI was effective in 
reducing alcohol consumption among high-risk youth in emergency care at 6 months and 12 
months follow-up  (Monti et al, 2007). In addition to providing brief MI, some of these 
studies offered booster sessions mostly with the aim of improving the long term effectiveness 
of the intervention (Bernstein et al, 2009). In most of the studies, the control groups also 
reported some reduction in substance use at least in the short-term.   
Despite the above mentioned positive results, three of the studies included in the review 
reported that brief MI was not as effective as reported in the other studies (Daeppen et al., 
2007; Marsden et al, 2006; Segatto et al, 2011). These studies reported no statistical 
difference in outcome measures between intervention and control groups. Whilst Marsden et 
al (2006) explained that screening, baseline assessment and interaction with researchers may 
account for their results, Daeppen et al (2007) argued that such activities may not be 
accountable for the similar effects in their study. In effect, there was no clear reason to 
explain why the intervention was not more effective. 
The review of the empirical evidence revealed a number of issues related to the effectiveness 
of brief MI. Firstly, the effectiveness of brief MI recorded in some studies was short term and 
was not sustainable in the longer term. Vasilaki et al (2006) for instance reported that brief 
MI was more effective in the first 3 months of follow up compared to effectiveness at 6 
months. Marsden et al (2006) reported that even though brief MI was not more effective 
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compared to providing information only at 6 months, their pilot study showed more 
effectiveness at 3 months.  
Secondly, different studies used different tools for screening and the assessment of outcome 
measures. Some studies used a combination of biological makers and self-report screening 
tools whilst others used either of the two. Monti et al (2007)  used BAC (Blood Alcohol 
Concentration) and AUDIT screening tool whereas McCambridge & Strang (2004) used self-
report.  Other studies used other assessment tools or questionnaires. Stein et al (2009) for 
instance used the Addiction Severity Index questionnaire to assess cocaine use among their 
study subjects. Substance use has different effects on users and brief interventions normally 
target different outcome measures and not just level of substance use. Studies therefore use 
different tools and questionnaires to assess their different outcome measures and this helps to 
evaluate the different outcome measures of interest. The study that is the topic of this thesis 
measured the level of risk of substance use with the ASSIST screening tool, depression with 
the Centre for Epidemiological Studies Depression Scale (CES-D) and the other outcomes 
measures with questionnaires designed for the study.  The use of different screening tools and 
assessments of the different outcome measures (which is very common in substance use 
studies) makes it difficult to compare study findings.  
Thirdly, brief MI offered to patients differed in duration and this may have some influence on 
the extent to which the intervention impacted on patient outcomes. No particular reasons 
were available for this practice in the available literature reviewed. In light of this, Vasilaki et 
al (2006) suggested the need for more studies into the issue. Their meta-analytic review 
showed that whilst MI was more efficacious than other interventions that lasted longer, it was 
also more efficacious than those offered within a shorter time frame like standard care and 
short advice. Besides the difference in duration, the interventions also had different 
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components even though they all included the main components of brief interventions – 
Feedback, Responsibility, Advice, Menu, Empathy and Self efficacy (FRAMES) (Humeniuk 
et al, 2010). 
All these notwithstanding, there is enough evidence to support the effectiveness of brief MI 
as an intervention for substance use.  
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Table 1: Summary of studies on the effectiveness of brief MI for substance use  


















– pilot study 







marijuana use.  
Youth and 












was used for 
screening. 
Brief MI compared to a standard assessed 
(AC) group and a non-accessed control 
(NAC) group. 
Intervention group received written advice,  
a 20-minute structured conversation based 
on motivational interviewing technique, 
resources, a 10-day booster telephone 3- 
and 12-month appointment;  The  standard 
assessed control (AC) group received 
resources, written advice, and 3- and 12-
month follow-up appointments; NACs 
received a resource brochure, written advice 
about marijuana use risks, and a 12-month 
follow-up appointment. 
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Table 1 continued 













2. (Bernstein et 
al, 2005)  












Patients 18+ years at 
out-patient clinics. 
RIA (radio-immune 
assay of hair) test and 
Drug Abuse Severity 
Test screening tool 
(DAST).  
 
One session of brief MI 
compared to no treatment. 




Brief MI has the 
potential of 
helping patients to 
achieve abstinence 
from cocaine and 
heroin use at 6 
months follow-up. 





To assess the 
efficacy of brief 
MI to minimise 
smoking.  
Adolescent patients 
between the ages of 
14–19 years in 
hospital outpatient 
clinic or emergency 
department. 
 Biomarker (saliva 
samples) and other tools 
including TWEAK, the 
timeline follow back, the 
Fagerstrom Tolerance 
questionnaire, etc. 
One session of 35 minutes 
MI compared to 5 minutes 
standardized brief advice.  
Intervention group also 
received 20-15 minutes 
booster session one week 
after baseline assessment. 




Brief MI was 
effective in 
reducing smoking 
at 3 and 6 months. 
 
RCT= randomised controlled trial; MI=motivational interviewing 
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Table 1 continued 
study Type(s) of 
substance 





Screening tool(s) Description of 
interventions 




Alcohol To evaluate the 
efficacy of brief 
alcohol intervention 
(BAI) in reducing 
alcohol use. To test 
if the effects of 
observation and 
assessments were 
accountable for the 
similar reduction in 
alcohol use among 
intervention and 



















control groups of 






Reduction in alcohol use was 
similar in all groups. 10–15-
minute BAI did not decrease 
alcohol consumption and the 
utilisation of other health 
resources among hazardous 
drinkers. Baseline 
assessment did not account 
for the similar reduction in 
alcohol use between the 
groups.  
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Table 1 continued 







Screening tool(s) Description of 
interventions 










in trauma units to 
reduce alcohol 
use and repeated 
trauma visits. 
Injured patients, 
aged, over 18 
years old 
admitted to 















compared to no 
intervention 
aside screening. 
6, 12 months 
and 3 years 
follow-up. 
Single 30 minutes MI session 
was effective in minimising 
alcohol use, alcohol related 
trauma injuries (47%), 
hospitalisation from injuries 
after 3 years (48%) and 
reduction in problem with 
the police. 
The intervention was most 
effective among moderate 
users who formed about 83% 
of the overall study 
population.  
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Table 1 continued. 







Screening tool(s) Description of 
interventions 
Study period Summary of Findings/ 
conclusions 
6. (Magill et al, 
2009)  
RCT 
Marijuana To assess the 
extent of 
marijuana use and 
related problems 
among  young 
alcohol 
consumers and 
their response to 
brief MI. 
Young adults 
between 18 to 













brief MI for 
alcohol use 
compared to feed 
back only (FO). 
6 and 12 
months follow-
up. 
Brief intervention for alcohol 
users was effective in 
reducing marijuana use in 
both groups at 6 months but 
reduction in marijuana use in 
the MI group continued even 
at 12 months follow-up 
contrary to the FO group.  
Days of combined alcohol 
and marijuana use was also 
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Table 1 continued. 
study Type(s) of 
substance 

















ecstasy.   
To probe into the 
effectiveness of  brief 
MI in encouraging 
positive attitude 
towards abstinence 
from the use of 
cocaine and ecstasy 
and the minimisation 
of the amount and 
regular use of alcohol 
and stimulants.   
 
Young adults and 
adolescent substance 
users between 16 
and 22 years, 




east England).  
The Alcohol Use 
Disorders Identification 
Test (AUDIT);    a 45 
minutes questionnaire;     
a validated Maudsley 
Addiction Profile (MAP); 




45-60 minutes brief 
MI compared to 
health risk 
information only.   
6 months 
follow-up. 
Brief MI was not 
more effective 
than information 
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Table 1 continued 







Screening tool(s) Description of 
interventions 
Study period Summary of Findings/ 
conclusions 
8.(McCambridge 
& Strang, 2004)  
Cluster 







To investigate the 




people or their 
view on risks and 
harm associated 
















MI was more effective in 
reducing substance use 
compared to education only 
even though the reduction in 
related risk and harm was not 
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Table 1 continued.  











Summary of Findings/ 
conclusions 
9. (Monti et al, 
2007)  
RCT 
Alcohol To test the 
efficacy of brief 




















One session of 30-40 
minutes MI that 
included personalised 
feedback compared to 
feedback only (FO). 
Booster sessions were 
conducted 1 and 3 
months post-baseline 
by telephone but it 
was more detailed for 
those in the MI 
group. 
6 and 12 
months 
follow-up.  
MI was more effective in 
reducing alcohol 
consumption compared to 
FO (effectiveness was   
maintained at 12 months 
follow-up). There was no 
significant difference 
between the interventions 
with respect to reduction in 
alcohol related problems. 
AUDIT=Alcohol Use Disorder Identification Test 
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Table 1 continued 






Screening tool(s) Description of interventions Study 
period 
Summary of Findings/ 
conclusions 
10. (Monti 
et al, 1999)  
RCT 
Alcohol To assess the 
efficacy of brief 
MI to reduce 


















35 -40 minutes of MI 
compared to standard care 
(normal treatment for youth 
involved in alcohol related 
injuries in emergency care 
which included self-help 
hand outs on drink-driving 
and a list of local treatment 
organisations). 
 
3 and 6 
months 
follow-up. 
Compared to standard care, 
brief MI was more 
effective in reducing 
alcohol related problems. 
Both groups reported of 
reduction in alcohol use 
especially in the first 3 
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Table 1 continued. 
study Type(s) of 
substance 








Summary of Findings/ 
conclusions 
11.(Segatto 
et  al, 2011)  
RCT 
Alcohol To assess the effectiveness of 
brief MI and educational 
brochure in minimising 
alcohol misuse and associated 
problems.   
Adolescents and 
young adults 
between the ages 
of 16-25 years 




within 6 hours of 
alcohol use. 
Self-report 




on alcohol use 




45 minutes of single MI 
session delivered by a 
senior psychologist plus 
reading and discussion of 
educational brochure 
compared to 5 minutes 
reading and discussion of 
3 paged risks of alcohol 
use and guides to 
minimise alcohol use or 






There was no 
statistical difference 
between the groups 
with respect to alcohol 






no matter how brief 
the intervention. 




cocaine To assess the effectiveness of 
multiple brief MI sessions in 
reducing cocaine use among 
the study population.  
Out-of treatment 
cocaine users 
over the 18 years 
of age.  
Addiction 
Severity Index 
(ADI) and the 
AUDIT. 
4 sessions of MI lasting 
between 20 to 40 minutes 
per session compared to 





MI was more effective 
in reducing cocaine 
use compared to 
assessment only. 
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Table 1 continued.  











Study period Summary of Findings/ 
conclusions 
13. (Vasilaki 

















were used to 
evaluate level 




Compared brief MI to no 
intervention and other 
brief interventions for 
alcohol (standard 
care/brief 
advice/treatment as usual, 







3, 6, 12, and 25 
months follow-
up. 
Brief MI was more 
efficacious compared to no 
intervention in the short-
term (3 months follow-up). 
It is also more efficacious 
when compared to the 
other interventions.  
 Brief MI was more 
effective in the first 3 
months of follow up 
compared effectiveness at 
6 months. 
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Theoretical overview of Problem Solving Therapy (PST) 
PST is a cognitive clinical behavioural treatment that equips patients with problem-solving as 
well as coping strategies and skills aimed at improving ‘psychological and behavioural 
functioning’ in order to minimise and/or avert mental disorders and manage life’s stressful 
issues more effectively (D’Zurilla & Nezu, 2010: p.179). Problem-solving is a process of 
ascertaining answers to particular problems (D’Zurilla & Nezu, 2010). It is a ‘behavioural 
process’ that offers the patient different ways of handling a problem and also promotes the 
likelihood of choosing the most effective alternative (D'Zurilla & Goldfried, 1971: p.107). 
Problem solving skills alone are however not enough. Depending on the nature and/or level 
of their problem, coping skills developed through PST enables patients to minimise their 
psychological distress and improve on their situations by helping them to accept their 
situation, eliminate any opposition to change, achieve their goals of change, develop 
tolerance and turn their problems around. An effective combination of these two skills helps 
to get the most out of PST. PST is based on models of social problem-solving and 
relational/problem solving models of stress and well-being (D’Zurilla & Nezu, 2010).  
Relational/Problem Solving Models of Stress and Well-Being 
The relational/problem-solving model of stress and well-being provides both a theoretical 
basis for PST and a useful outline for assessment before PST is offered. It is a broad and 
resourceful coping strategy. Prior assessments help to apply PST in a way that helps to 
improve the elements of problem solving that enhances positive outcomes and minimise or 
prevent those elements that lead to negative outcomes (Bell & D'Zurilla, 2009; D’Zurilla & 
Nezu, 2010).   
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Social Problem-Solving Model 
Social problem-solving is a ‘learning process, a general coping strategy and a self-control 
method’ (D’Zurilla & Nezu, 2010: p.198). It is more related to real life problems and stress 
and how the patient is able to comprehend, evaluate and cope with such situations. The 
problem solving model was developed by D’Zurilla & Goldfried in 1971 and then modified 
by D’Zurilla & Nezu in 1982 and 1990. It theorised that there were two methods of problem 
solving – problem orientation and problem solving skills (Bell & D'Zurilla, 2009; D’Zurilla 
& Nezu, 2010). 
Problem-solving orientation 
Problem-solving orientation is explained to be a set of consistent responsive reasoning 
patterns that show how individuals recognise and evaluate the problems they face in life and 
their ability to solve those problems. It thus plays a ‘motivational function’ in the process of 
problem solving (Bell & D'Zurilla, 2009: p.349; D’Zurilla & Nezu, 2010: p.200). There are 
two problem solving orientations, positive and negative problem solving orientations. People 
with high positive problem solving orientation have a positive attitude towards their problems 
whilst the opposite is true for those with high negative problem solving orientation.    
Problem solving skills 
Problem solving skills are actual actions (both mental and behavioural) relating to an 
individual’s efforts to comprehend everyday problems and come up with coping strategies to 
effectively handle the problem (Bell & D'Zurilla, 2009; D’Zurilla & Nezu, 2010). D'Zurilla 
and Goldfried (1971) presented four problem-solving skills which include creation and 
recognition of problems, creation of different solutions, making of decisions, and 
confirmation and application of solutions. D’Zurilla and Nezu (2010) later explained that the 
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latter skill is not about the actual implementation skill of the person but rather how he/she 
observe and appraise his/her solution after and whilst executing it.  
Scales for measuring patient’s social problem solving 
D’Zurilla and Nezu developed the social problem solving inventory (SPSI) which is made up 
of the problem orientation scale (POS) and the problem solving skills scale (PSSS). These 
scales were based on the original 1971 model and measure cognitive, emotional and 
behavioural problem solving characteristics of the individual. It was a 70 item self-report 
scale developed to provide a theoretical basis for the measurement of social problem solving 
for research and clinical assessments that is precise and valid. SPSI was later revised into a 
five-element model made up of problem orientation elements – positive problem orientation 
(PPO), negative problem orientation (NPO) – and elements of problem-solving techniques –
rational problem solving (RPS), impulsivity/carelessness style (ICS) and avoidance style 
(AS). These are the five dimensions of social problem solving model. The positive problem 
orientation and the rational problem solving are the positive dimensions and enhance positive 
problem-solving results whilst the remaining three elements are the dysfunctional dimensions 
that work in the opposite way (D’Zurilla & Nezu, 2010; D’Zurilla et al, 2002). As part of the 
main STRIVE study, patients’ social problem solving were assessed based on these 
dimensions (results are not presented as part of the current cost-effectiveness analysis).  
The social problem solving inventory-revised (SPSI-revised) was developed to measure the 
five elements of social problem solving. It is a self-report instrument and is used to assess a 
person’s problem solving skills in order to help develop those skills where they are lacking. 
There is the long version (SPSI-R: L) which is a 52-item instrument and the short version 
(SPSI-R: S) which is a 25-item instrument and can be used in a time constrained environment 
or situation. The difference between the two versions is that in addition to the five main 
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elements, the long version also measures the four subscales of rational problem solving which 
are ‘problem definition and formulation’; ‘generation of alternative solutions’; ‘decision 
making’; and ‘solution implementation and verification’ (D’Zurilla & Nezu, 2010: p.201; 
D’Zurilla et al, 2002). The SPSI-R is reported to be useful in a wide range of settings 
(including clinical, educational and research settings) and useful to all calibres of people 
interested in the mental and emotional welfare of people. It is not difficult to administer and 
score therefore non-mental health workers as well as other health workers can use it with 
ease. In scoring the SPSI-R, higher scores in the positive dimensions (PPO and RPS) is 
associated with positive problem-solving results whilst higher scores in the dysfunctional 
dimensions is associated with flawed problem solving results (D’Zurilla et al, 2002).   
Empirical evidence of PST as a brief intervention for substance use 
The underlying theory of PST is supported by empirical evidence (D’Zurilla & Nezu, 2010). 
The efficacy and appropriateness of PST in different adolescent and adult populations has 
been reported in a number of studies ranging from clinical randomised control trials to 
psychology outcome studies (Bell & D'Zurilla, 2009; Cuijpers et al, 2007; D’Zurilla & Nezu, 
2010). It has been reported to be effective in the treatment of mental disorders such as major 
depression, anxiety, emotional distress, suicidal thoughts and personality disorders (Society 
of Clinical Psychology, n.d.). There is enough evidence of its effectiveness for some mental 
as well as some physical disorders (Bell & D'Zurilla, 2009; Cuijpers et al, 2007; Malouff, 
Thorsteinsson & Schutte, 2007).  
Unlike studies on other mental disorders, no published studies on the effectiveness of PST as 
an intervention for substance use and related problems were found during the literature search 
for this work. The only evidence of effectiveness available (unpublished) was the results of 
the STRIVE study. It was found that a combination of PST and MI as brief interventions for 
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substance use disorder was effective in reducing depression and patient’s ASSIST score 
(which reflected reduction in substance use) among at risk substance users in emergency 
departments (Sorsdahl et al, unpublished data). Despite the lack of numerous effectiveness 
studies in the area of PST and substance misuse as compared to MI, the result of the STRIVE 
study is promising.   
Theoretical overview of methods of economic evaluation 
In economic theory, an interaction between demand and supply in a perfectly competitive 
market leads to the efficient allocation of resources. This is however limited in the health care 
market because the conditions of a perfectly competitive market do not hold. There is 
uncertainty about the occurrence and duration of diseases, problem of asymmetry of 
information between providers and consumers of health care, irrational behaviour of 
individuals when sick and monopoly in the health market (Walker et al, 2011). This 
notwithstanding, equitable and efficient allocation of health care resources is important given 
the scarcity of health care resources as against the increasing demand for health and health 
care. Decisions about treatment options and interventions to implement must be made to 
ensure that resources are efficiently distributed. Methods of economic evaluation of 
alternative interventions or programs aid in such decisions (Cowell et al, 2010; Drummond et 
al, 2005; Walker et al, 2011). Economic evaluations ‘identify, measure, value and compare’ 
costs and effects of competing alternatives (Drummond et al, 2005: p.9). It deals with the 
issue of choice between alternatives by considering and comparing their costs and 
effectiveness. Based on this, economic evaluation has been defined as ‘the comparative 
analysis of alternative courses of action in terms of both costs and consequences’ 
(Drummond et al, 2005: p.9). 
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Economic evaluation of mental health services like other health services is important. Such 
analysis helps to address issues of resource allocation between mental health services and 
services for other physical illness and sectors of the economy by gathering the necessary cost 
information (Weisbrod, 1993). The determination of the societal costs of mental health 
disorders including substance use disorders is however difficult. These usually take account 
of a wide range of costs that may not be monetary and are usually covered in other sectors 
outside the health sector and mental health services like the legal and law enforcement 
services (Weisbrod, 1993). 
There are four main methods of economic evaluation – cost analysis, cost-effectiveness 
analysis (CEA), cost utility analysis (CUA) and cost-benefit analysis (CBA), even though 
cost-analysis is not considered a full economic evaluation method (Drummond et al, 2005). 
All of these methods are similar in their cost measurement and valuation but differ in their 
outcome valuation. The main advantages, limitations and differences between these methods 
are summarised in table 2 below. 
Methods of economic evaluation are associated with micro-economic theories/viewpoints of 
welfarism and non-welfarism. These influence the method used and the policy suggestions to 
be made from such analysis (Walker et al, 2011). For instance, CBA is said to be based on 
the Kaldor-Hicks welfare theory of potential Pareto improvement whereby gainers of a policy 
compensate the losers of the policy in order for societal welfare to increase. CEA is mostly 
based on non-welfare theories which favour the maximisation of targeted health outcomes 
and does not place much emphasis on the maximisation of people’s utilities which is the 
focus of welfare theories (Walker et al, 2011).  The type of analysis chosen also depends on 
the problem being analysed, difficulty with measurement and/or valuation of outcome and the 
analyst’s view on the role of economic evaluation (Drummond et al, 2005).  Despite these, it 
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cannot be ignored that the intended purpose of the analysis and the data available to the 
researcher can also play key role in the selection of the method to use. 
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Table 2: Summary of differences and limitations of the main methods of economic evaluation 
Type of 
evaluation 
Outcome measures Measurement/valuation of 
outcomes 
Decision making Advantage/ limitations limitations 
Cost-
analysis 
Does not include outcomes 
in the analysis. 
Not applicable. Based on the cost per 
intervention. Lower costs 
are preferred. 
Easier to conduct 
compared to the others. 
Not a full economic 
evaluation. 
CEA Single outcome measure 
for both interventions 
being compared. 
Natural units. Example, life 
years gained, reduction in 
substance use, etc. 
Based on *ICERs per LYs 
gained/saved/lost. Lower 
ICERS are preferred to 
higher ones in most cases.  
Easier to compute 
outcomes in natural units. 
Difficult to compare cost-
effectiveness of 
interventions across 
different programs or 
sectors of the economy. 
CUA Outcome measures may 
not be similar to 
alternatives being 
compared and it may also 
be more than one outcome 
measure. 
Healthy years, usually 
measured in Quality 
Adjusted Life Years 
(QALYs) with reference to 
people’s health related 
quality of life.  
Based on cost per QALY 
gained or cost per healthy 
years. Lower values are 
preferred. 
Computes outcomes in a 
single comparable unit 
(QALYs). 
Not always easy to 
convert outcome measures 
into QALYs. 
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CBA Outcome measures may 
not be similar to 
alternatives being 
compared and it may also 
be more than one outcome 
measure. 
Monetary terms based on 
people’s willingness to pay. 
Based on #net present 
values presented as cost-
benefit ratios or benefit-
cost ratios. High positive 
net values are preferred. 
Allows for comparison of 
outcomes across different 
programs and sectors of 
the economy. Enhances 
sectorial decision 
making.   
Not always easy to 
compute outcomes in 
monetary terms. 
Sources: (Cowell et al, 2010; Drummond et al, 2005; Luce & Simpson, 1995; Walker et al, 2011) 
* Incremental cost-effectiveness ratios (ICERs) are measured as a ratio of additional costs to additional effectiveness of alternative interventions.
# Net present values are calculated as the difference in the costs and benefits of the interventions being compared.
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Empirical evidence of economic evaluation studies on screening and brief interventions 
for substance use. 
A number of economic evaluation studies have been conducted on treatment services for 
substance abuse and addiction (Barnett & Swindle, 1997; Cartwright, 1998; French, 2000; 
French et al, 2002; French et al, 2000; Mojtabai & Graff Zivin, 2003; Schumacher et al, 
2002).  Most of these focused on alcohol use with very few on brief interventions for 
hazardous substance use (Kunz et al, 2004). For the purpose of this review, only brief 
interventions for substance use, specifically those that incorporated MI or PST were included. 
Studies that focused on other forms of brief interventions apart from those mentioned above 
as well as those that focused on treatment services for patients with dependence problems 
were excluded. In addition to the cost-effectiveness studies, other economic evaluation 
studies on brief interventions for substance use were also included. No published studies on 
economic evaluation for PST as a brief intervention for substance use were found. None were 
therefore included in this section of the review.  
Cost-effectiveness Studies 
In all, six published cost-effectiveness studies were reviewed. Three of these involved 
emergency departments. All the studies with the exception of one, focused on interventions 
for alcohol use. A summary of cost-effectiveness studies reviewed are presented in Table 3. 
The empirical evidence showed that screening and brief interventions for substance use can 
be cost-effective. At 6 months follow-up, Barrett et al (2006) reported that 45 minutes brief 
intervention for alcohol use in emergency departments was cost-effective compared to just 
screening and providing patients with hand-outs with information on alcohol consumption. 
As part of a pilot study, Kunz et al (2004) also reported that screening and brief interventions 
in emergency departments has the potential of being cost-effective compared to providing 
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only information after screening. Brief MI for teenagers presenting at emergency departments 
with alcohol related problems was reported to be cost-effective compared to standard care of 
5 minutes of brief advice on risky alcohol behaviours (Neighbors et al, 2010). Among low-
income pregnant women who quit smoking, brief MI was reported to be more cost-effective 
in the prevention of relapse compared to usual care (Ruger et al, 2008). Combinations of MI 
with other brief interventions have been reported to be more cost-effective. A study among 
college freshmen reported that MI combined with feedback was more cost-effective 
compared to MI only, feedback only and no intervention at all (just assessment of alcohol 
consumption and risk level). MI or feedback only was more costly and less effective (Cowell 
et al, 2012).  
Contrary to the positive results of the cost-effectiveness of brief MI reported above, the 
intervention has been reported to be more costly but not more effective in getting low-income 
pregnant women to stop smoking compared to usual care  (Ruger et al, 2008). 
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Table 3: Summary of cost-effectiveness studies 































A 45-minutes single 
















losses, cost of 
resources of the 
criminal justice 
system, other 




The intervention was 
more effective and 
slightly less costly 
compared to information 
only leading to an ICER 
of £22 per reduction in the 
units of alcohol consumed 
in a week.  
The intervention cost or 
cost to the health sector 
was the highest cost 
component followed by 
the cost to the social 
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Table 3 continued 


















the cost and 
cost-
effectiveness 













































interventions.   
MIFB dominated all the interventions and 
resulted in an ICER of $47.04 per 
reduction in the average number of drinks 
consumed in a drinking period and $64.34 
per reduction in the number of days of 
periodic heavy alcohol consumption. 
At a willingness to pay value of $47 and 
$64 per reduction in the average number of 
drinks and the number of days of periodic 
heavy alcohol consumption respectively, 
AO could be the most cost-effective 
intervention. Beyond those values, MIFB 
would be preferred. 
Included only 
short term 
costs of the 
intervention. 
Fixed costs 
like costs of 
computers 
and training 
for staff were 
excluded 
from the 
analysis.   
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Table 3 continued 










Range of costs  Summary of 
results/conclusion 
Comment(s) 
3. (Kunz et 
al, 2004)  
 
To evaluate 









population in an 
emergency 
department of 





















Costs of screening 
and intervention 
made up of staff 
wages, costs of 
equipment used, 
incentives paid to 
patients for 





for substance use 
can be cost-
effective. 
Did not include 
costs to patients.  
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Table 3 continued 














et al, 2010) 
 
 
To assess the 
cost-
effectiveness 



























Cost of intervention 
– staff time used in 
the delivery of the 







overheads.   
MI was more cost-
effective compared to 
standard care for all 
the outcome measures. 
ICER per reduction in 
drinking and driving, 
alcohol related 
injuries, traffic 
violations and alcohol 
related problems were  
$362.04 to $375.96, 
$591.33 to $614.07, 
$387.34 to $402.23 
and $953.76 to 
$990.43 respectively.  
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Table 3 continued 
















To assess the 
cost-
effectiveness 

















About 1 hour brief 
MI delivered during 
3 home visits to the 
women plus self- 
help brochure on 
smoking cessation 
compared to care as 
usual (prenatal care 
and approximately 5 
minutes intervention 
on the risks of 
smoking for 
pregnant women and 
new mothers plus 
self-help resources).  
Infants Health 
outcomes at 








smokers and the 
Life years and 
QALYs saved 





1. Cost of 
intervention – cost of 
staff time for the 
delivery of the 
interventions, cost 
incurred in the 
analysis of nicotine in 
the environment, staff 
training cost, travel 
time and cost of self-
help resources. 
2. Cost saving from 
averted neonatal and 
maternal medical 
costs. 
MI was more costly 
and not more 
effective compared 
to UC with respect 
to smoking 




MI was more costly 
and more effective 




Not all costs 
were included 
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Table 3 continued 
















To assess the 
cost-
effectiveness 





Screening and 10 
to15 minutes brief 
counselling 
compared to 
current practice of 








Cost of health 
care which 





















Study did not 
include cost to 
participants.  
Discounted both 
cost and effects 
but at different 
rates. 
 
63 | P a g e  
 
There are a number of methodological issues arising from these studies. Unlike traditional cost-
effectiveness studies where there are common outcome measures like life years (LYs) gained, 
life years lost, life years saved, etc., there is a lack of agreement on a single common outcome 
measure for cost-effectiveness studies on substance use (Barbosa et al, 2010; Cowell et al, 2010). 
This was evident in the studies reviewed above.  With the exception of two studies that used 
QALYs and LYs gained (Ruger et al, 2008; Tariq et al, 2009), all the other studies used different 
outcome measures. These were however centred on substance use and/or related problems. The 
outcome measures of the studies reviewed are presented in table 3. Like the studies reviewed, the 
study reported in this thesis does not use QALYs and LYs but measures outcomes in natural 
units. The outcome measures used were different from those used in published studies. In 
addition to measures on substance use based on patients’ ASSIST scores which has not been 
reported in any of the published studies reviewed it also includes measures on verbal argument 
and depression as secondary outcomes.  
The perspective taken in an economic evaluation is important. It delineates the point of view of 
the analyst, and also influences the range of costs and outcomes to be evaluated in the study. It 
drives the design of the analysis (Luce & Simpson, 1995). The perspectives and range of costs of 
the studies reviewed are also presented in table 3. Four of the studies reviewed used providers 
perspective in their analysis (Cowell et al, 2012; Kunz et al, 2004; Neighbors et al, 2010; Tariq et 
al, 2009). These studies were focused on providers’ decision making. However, the use of 
provider’s perspective does not provide the full cost of these interventions. It excludes the costs 
to patients, their families and costs from other sectors of the economy that are affected by 
substance use like the justice system, law enforcement, labour market and educational sector. 
Besides, the effects of substance use go beyond health outcomes. The social consequences are 
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usually even higher than the health consequences leading to higher social costs.  Excluding such 
costs hinders the accurate analysis of the true costs and in some cases the effects of these 
interventions.  Even though the current study aims to inform provider’s decision making, it 
employs societal perspective which allows for the consideration of other social costs including 
costs to patients for taking part in the intervention. 
Sensitivity analysis is an important aspect of economic evaluation. It tests the strength of study 
findings by varying the study parameters (Briggs, 1995). The four main methods of sensitivity 
analysis identified by Briggs (1995) are simple sensitivity analysis, extreme scenario analysis, 
threshold analysis and probabilistic sensitivity analysis.  All the studies reviewed conducted 
sensitivity analysis. Whereas some of them conducted either simple sensitivity analysis (Ruger et 
al, 2008) or probabilistic sensitivity analysis (Kunz al, 2004; Tariq et al, 2009), others conducted 
a combination of the two (Barrett et al, 2006; Cowell et al, 2012; Neighbors et al, 2010).  Barrett 
et al (2006), Cowell et al (2012) and Tariq et al (2009) employed cost-effectiveness acceptability 
curves to evaluate uncertainty around their incremental cost-effectiveness ratios (ICERs). The 
present study conducted a simple sensitivity analysis. With the exception of Cowell et al, (2012) 
and Ruger et al, (2008), the results of the sensitivity analysis of the other studies supported the 
initial findings reported by the authors. The one-way sensitivity analysis by Ruger et al, (2008) 
showed that even though MI was more costly and less effective in encouraging smoking 
cessation among their participants in the initial analysis, 8% cessation rate among smokers could 
make the intervention cost-effective.  
Discounting is another important aspect of the evaluation of programs (Olsen, 1993) and is thus 
encouraged in economic evaluation of health care programs or interventions. It gives a view of 
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future costs and effects in present terms (Drummond et al, 2005). Whereas discounting costs in 
economic evaluation is not a disputed issue, there are a number of arguments for and against the 
discounting of health effects.  Whilst some authors argue in favour of the discounting of health 
effects equally as costs, others argue against equal discounting or no discounting at all 
(Drummond et al, 2005). Drummond et al (2005) mentioned that in all these, the researcher 
should take into consideration the context of the economic evaluation. Given that brief 
interventions for substance use are effective in reducing negative consequences of substance use 
and future health care costs (Gentilello et al, 2005), some of the studies reviewed discounted 
either their costs or effects or both. Tariq et al (2009) discounted both costs and effects at 4% and 
1.5% respectively. Ruger et al (2008) also discounted effects of the interventions. However, not 
all studies discounted their costs or effects. Whilst some totally ignored it without any reason, 
others explained that discounting was not necessary because costs and benefits did not exceed 
one year (Barrett et al, 2006). Cowell et al (2012) excluded long term costs and effects and so did 
not need to discount these. In addition to not discounting, some studies failed to annuitise their 
costs even though they included capital costs. In most situations these were treated like recurrent 
costs. Even though the current study does not discount overall intervention costs and effects of 
the intervention given that these were all incurred over a short time frame of less than a year, 
capital costs were discounted and annuitised to extract the monthly costs of those resources. 
Most of the studies assessed cost-effectiveness by calculating the ratio of the incremental costs 
and effects of the interventions to the comparators (Barrett et al, 2006;  Cowell et al, 2012;  Kunz 
et al, 2004;  Ruger et al, 2008;  Tariq et al, 2009). Neighbors et al (2010) used decision analytic 
models to compute ICERs. The current study used decision analytic model (decision tree) to 
assess cost-effectiveness of the interventions.   
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Other Economic Evaluation Studies 
Only one published cost-benefit study of brief interventions for substance use in emergency 
departments was found and reviewed. Gentilello et al (2005) provided brief alcohol intervention 
to injured patients in emergency departments and hospitals and reported that the intervention was 
cost-effective. The intervention led to reduction in emergency department visits and 
hospitalisation at a lower cost, leading to a net cost saving of $89 for each patient screened or 
$330 for each patient to whom an intervention was offered. Each $1 spent on screening and brief 
intervention led to $3.81 savings in health care cost. Unlike the present study, this study focused 
on alcohol only. It included only the direct medical costs for alcohol related injuries. It did not 
include other medical costs, costs to patients for attending the emergency departments or hospital 
or participating in the interventions and other social costs (Gentilello et al, 2005). 
In another cost-benefit study, brief physician advice to problem drinkers was reported to be cost-
effective leading to a benefit: cost ratio of $56,263:$10,000 (Fleming et al, 2000). An 
intervention cost of $205 per patient led to a benefit of $1,151 in monetary terms. Comparing 
cost of intervention to its effectiveness, the authors reported that the intervention led to an 
economic benefit of $ 195,448 in savings from reduction in hospital and emergency department 
visits and $ 228,071 in averted cost of crime and automobile accident reductions (Fleming et al, 
2000). 
 Among older alcohol users between the ages of 65 and 75 years old, brief physician advice was 
reported not to be very cost-effective (Mundt et al, 2005). There was no statistical difference in 
the monetary value of change in the use of health care services and alcohol-related social effects 
between the intervention and control groups. However, compared to other treatment services 
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provided in out-patient departments, the authors reported that the intervention was more effective 
in minimizing alcohol consumption among hazardous drinkers at a lower cost of $236. Although 
cost-benefit allows for easier comparison of costs and benefits of interventions in monetary 
terms and across different sectors of the economy, the main limitation to the use of the method is 
the difficulty in converting outcomes into monetary terms. Such conversions were beyond the 
scope of the present study. 
In a cost-utility analysis, Neighbors et al (2010) provided evidence that brief MI for alcohol was 
more cost-effective compared to standard care. The combined cost per QALY gained for both 
men and women was $8,795 per QALY and this was reported to be preferred to other medical 
technologies (Neighbors et al, 2010). The authors compared lives saved by the intervention and 
its incremental costs. Unlike most of the studies reviewed, the cost-utility study used a single 
outcome measure (QALYs). In emergency departments where a lot of the patients are injured or 
are in some form of extreme pain, using a health related quality of life scale to measure people’s 
health state can be biased by their current health state. In the current study, about 72.2% of the 
study participants were injured (Sorsdahl et al, unpublished work).  
Task-shifting 
Task-shifting is when people with lesser qualifications are given some amount of training to 
undertake a task that could otherwise have been done by those with higher qualification. It is also 
when tasks are redistributed such that lower qualified workers do the jobs that should have been 
done by more qualified professionals (Fulton et al, 2011). Based on a review of literature on 
task-shifting or task substitution, Dovlo (2004) identified four main forms of task-shifting or 
substitution in Africa: (1) using existing but different group of health workers in place of another 
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group – example, nurses doing the work of physicians; (2) replacing or substituting existing roles 
with new or different ones – example, medical assistants taking the role of physicians; (3) 
assigning specific roles to less trained group of workers from the same profession – example,  
assigning specialist work to general practitioners; (4) assigning non-technical tasks to others to 
minimise work load. Using peer counsellors for screening and brief interventions for substance 
use in emergency departments fits more in the fourth category. Given the nature of economic and 
health problems in most developing countries, task shifting in the health sector provides a 
favourable way of acquiring health care at reasonable cost despite its challenges. It provides the 
opportunity to fill in the gap in heath service delivery (Dovlo, 2004). According to Fulton et al 
(2011), it increases production efficiency in the health sector by leading to the provision of more 
health care services at a given cost and quality or the same quantity and quality of health care at 
a lower cost. Such efficiency leads to improvement in health service delivery. It also reduces cost 
of training and wage payment to highly skilled workers. Task shifting also minimises the time 
needed to increase the workforce since it takes lesser time to train people to undertake shifted 
tasks (Fulton et al, 2011). 
Given the gaps in the mental health services in South Africa, Petersen et al (2012) reported that 
at minimal cost, task shifting in the mental health sector can bridge the mental health service 
delivery gap in South Africa. They calculated the cost of a hypothetical human resource mix 
required to provide mental health services in rural settings in the country. In the area of screening 
and brief interventions for substance use, many of the studies reviewed above have used non-
traditional mental health workers like physicians, physician assistants, health 
educators/promoters, peer health educators, etc. who were given special training to screen 
patients, offer brief interventions and in some cases make referrals for specialist care. The use of 
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these non-mental health professionals was feasible and resulted in effective intervention delivery 
and outcomes. In the South African setting, a pilot study has shown that the use of peer 
counsellors to provide screening and brief interventions for substance use in emergency 
departments has been reported to be feasible with limited cost (Myers et al, 2012).  
A cost-analysis by Zarkin et al (2003) reported that the cost of screening and brief interventions 
for alcohol is fair and even cheaper when delivered by lower level health workers. Most of the 
economic evaluation studies on the topic concentrated more on the cost analysis of the total 
intervention without providing an explicit cost analysis or cost description on task-shifting even 
though they used non-mental health workers (Babor et al, 2006;  Kunz et al, 2004;  Neighbors et 
al, 2010). The current study provides an explicit analysis on the costs of using peer counsellors 
for screening and brief intervention in emergency departments. Unlike the study by Zarkin et al 
(2003), the current study involved peer counsellors rather than traditional mental health workers.  
Summary and conclusion 
The review of literature revealed that screening and brief interventions that employ motivational 
interviewing for substance use in emergency departments are feasible and effective.  In-spite of 
the available evidence of the effectiveness of the intervention, only a few of the published 
literature included other psychoactive substance besides alcohol. The review also reveals that 
different studies used different screening tools and targeted different outcome measures even 
though they were mostly related to substance use and related problems. Brief motivational 
interventions were offered at different durations ranging from 5 minutes to 45 minutes per 
session. Only short-term effectiveness mostly between 3 to 12 months follow-up was reported in 
the reviewed studies. This was due to the high loss to follow-up in these studies. This is not 
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surprising given the fact that the participants are substance users and have a high potential not to 
be committed to the program.  
Like the effectiveness studies, very few published cost-effectiveness analyses on the subject 
were identified. Despite this, those available provided enough information to inform the 
methodology of the current study. For instance it could be deduced from the literature review 
that there is no one way of measuring outcomes included in the economic evaluation. 
Incremental cost-effectiveness ratios can be reported according to the outcome measure used for 
the effectiveness analysis. 
The main gaps identified in the current literature on cost-effectiveness analysis of screening and 
brief interventions were that only few studies have been conducted in emergency departments, 
on other psychoactive substances other than alcohol, on PST as a brief intervention for substance 
use and none of the studies were conducted in the South African setting.  Other gaps identified 
were the fact that none of the studies used the ASSIST for screening and neither included 
outcome measures on verbal arguments and depression. Although the use of non-traditional 
mental health workers for screening and brief interventions for substance use was common in 
most of the studies reviewed, none of these studies provided an explicit cost analysis or 
description of task-shifting.  
In conclusion, even though screening and brief interventions for substance use are reported to be 
feasible and cost-effective in reducing substance use and related problems, there are still some 
gaps in literature that the current study aims to address, paramount of which is the fact that there 
is no published literature on the subject from the South African setting. 
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Abstract 
Background: This study is part of Project STRIVE (Substance use and Trauma Intervention) 
study which investigated the effectiveness of two brief interventions in reducing harmful 
substance use in patients presenting to emergency departments at three health facilities in the 
Western Cape Province of South Africa. The two interventions, offered by peer counsellors, 
were motivational interviewing (MI) or MI together with problem solving therapy (PST). The 
objective of the study is to assess the cost and cost-effectiveness of the two interventions from 
the provider and societal perspectives and to compare these to a no intervention status quo.  
Method: 335 patients were randomised into a control (n=110) or intervention (n=225) arm after 
being screened with the Alcohol, Smoking, and Substance Involvement Screening Test 
(ASSIST). Patients in the intervention group either received 1 session of MI (n=113) or MI in 
addition to 4 sessions of PST (n=112). Costs included in the analysis were the direct health care 
costs associated with running the interventions and screening for substance use as well as the 
costs of emergency department visits. Patient costs included any out of pocket payments incurred 
accessing the interventions. Outcome measures were patient’s ASSIST scores on substance use, 
depression and frequency of verbal arguments.  
Results: Both interventions were more effective than the control. The total cost per patient was 
R 83.48 for screening, R 779.89 for the MI only intervention and R 1093.36 for the MI with PST 
intervention. For patient’s ASSIST score and depression, the MI with PST intervention had a 
lower ICER than the MI (R340.66 and R133.46 per mean point reduction in ASSIST score and 
depressive symptoms respectively). For verbal arguments, the MI only intervention had a lower 
ICER of R3500.48 per mean reduction in the frequency of the outcome measure. The results of 
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the sensitivity analyses were not very different from the results of the initial analysis. It also 
showed that increasing the number of patients who screened positive and thus received the 
intervention could increase the effectiveness of the intervention. 
Conclusion: A combination of PST and MI delivered by peer counsellors can be cost-effective 
strategy for the minimisation of substance use and depression in emergency departments. 
Keywords: Substance use; emergency departments; brief interventions; motivational 
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Background 
Substance use is a public health problem accounting for a number of diseases and deaths globally 
[1]. It is associated with interpersonal violence, vehicular accidents and injuries [2-4]. Most of 
the victims of these incidences are treated in emergency departments [5-9]. South Africa has a 
long history of substance use disorder, particularly alcohol misuse [10] and is one of the 
countries with the highest prevalence and risk rate of substance use disorder in the world[11, 12]. 
Given the high rate of substance misuse in the country, the services available in the country to 
help substance users are relatively inadequate and are mostly treatment services aimed at helping 
those with dependence problems [13, 14]. Brief interventions for substance use are targeted at 
risky users who do not have dependence problems and may not be using treatment services. The 
aim is to help them quit or at least minimise their substance use [15]. In some situations, these 
interventions help those with dependence problems to enter treatment services and/or adhere to 
treatment [16].  
Brief interventions for substance use in emergency departments have been reported to be 
effective in reducing substance use, injuries and readmissions into emergency departments [17-
20]. Most of these interventions employ motivational interviewing techniques [21].  
Despite the proven effectiveness of these interventions and the fact that emergency departments 
are reported to be ideal for the provision of brief interventions for substance use, this is usually 
not the case [6, 7]. Emergency departments are usually swamped with severely injured or sick 
patients and health workers in these departments are almost always overwhelmed with work, 
with little or no time to screen and offer brief interventions for patients with substance use 
problems. To help deal with the problem of shortage of medical staff as well as the problem of 
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work-overload in these settings, task-shifting in medical settings has been recommended [22]. 
Task shifting has been described as the use of other workers to perform a task other than those 
traditionally trained or responsible for doing it [22]. It could take the form of task delegation or 
redistribution. Usually, those given the new task have lower qualification than those originally 
trained to do the work and are specifically trained to take on the task [22]. In this study task-
shifting denotes the use of peer counsellors for screening and the delivery of the brief 
interventions instead of clinical psychologists. The use of non-traditional mental health workers 
or general health workers for screening and the delivery of brief interventions in emergency 
departments has been reported to be feasible and in most cases encouraging of effective patient 
outcomes [23, 24]. 
Economic evaluation of brief interventions is important to aid decision making about their 
implementation by comparing the costs and effectiveness of the interventions. Not many 
economic evaluation studies have been conducted on the subject especially cost-effectiveness 
analysis. The few available published cost-effectiveness studies involving emergency 
departments mostly focused on patients with alcohol problems without much focus on other 
substance users. There is no agreed outcome measure for use in cost-effectiveness analysis of 
brief interventions for substance use [25]. The use of different types of costs and outcome 
measures in these analyses is common practice and this makes comparison of results of studies 
on the subject difficult [26]. 
Kunz, French and Bazargan-Hejazi provided brief counselling sessions and health information to 
problem drinkers presenting in emergency departments as part of a pilot study [27]. Their costs 
were mainly treatment and screening costs and their outcome measures were participant’s scores 
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on the AUDIT (Alcohol Use Disorders Identification Tests), average number of drinks consumed 
per week and cases of heavy drinking over 3 months of follow up. The average cost of the 
intervention per patient was reported as $632 and the screening cost ($497) formed about 79% of 
this cost. The intervention was found to be cost-effective in that setting, leading to incremental 
cost effectiveness ratios (ICERs) of $258 per reduction in patient’s AUDIT scores, $219 per 
reduction in average number of drinks consumed per week and $61 per reduction in probability 
of heavy drinking during 3 month follow up [27]. 
A cost-effectiveness analysis of brief MI compared to standard care of 5 minutes of brief advice 
offered to teenagers with alcohol related problems in emergency departments also reported that 
MI was relatively more cost-effective [28] . Costs included in the study were intervention costs, 
costs of the hand-outs used, staff training, costs of a computer program that prepared the 
feedback used during the intervention and overheads. Outcome measures were reduction in 
drinking and driving, road traffic violations and injuries associated with alcohol consumption. 
Decision analytic model was used to assess the cost-effectiveness of the interventions [28].  
45 minutes brief intervention following a referral to Alcohol Health Workers (AHWs)  has been 
reported to be more cost-effective compared to just receiving health information [29]. Patients’ 
alcohol consumption was measured at baseline and at 6 and 12 months follow-up to assess 
effectiveness of the intervention. Cost of all services used (hospital, community and social 
services), cost of productivity losses and intervention costs, mainly costs of the AHWs were 
assessed from a societal perspective. The findings of the study showed that costs and outcomes 
were slightly higher for the intervention group even though there was no statistically significant 
difference between control and intervention groups at 12 months follow up [29].  
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Unlike most of these studies, the current study included users of other illicit substances like 
cocaine, cannabis, amphetamine type stimulants (mostly tik), inhalants, sedatives or sleeping 
pills, hallucinogens and opioids. The study was part of Project STRIVE which offered two brief 
interventions, a combination of problem-solving therapy (PST) with motivational interviewing 
(MI) or just motivational interviewing to patients attending emergency departments in the 
Western Cape province of South Africa. The interventions were offered by peer counsellors 
[Sorsdahl et al, unpublished observation]. The inclusion of PST was to help patients develop and 
practice the skills needed to deal with problems of life. This cost-effectiveness analysis 
component aimed at assessing the costs and cost-effectiveness of these interventions. It also 
estimated the cost of emergency department visits and the cost of task-shifting, i.e. the cost of 
using the peer counsellors instead of clinical psychologist for screening and the administration of 
the interventions.  
Methods 
Study Design 
Cost-effectiveness was assessed from both provider and societal perspectives. Outcomes and 
costs were extracted from the STRIVE study. Both the ingredients and step down methods were 
used to calculate the economic cost of interventions. Cost-effectiveness analysis was estimated 
by computing the incremental cost-effectiveness ratios (ICERs) of the interventions. A decision 
analytic model (decision tree, built in TreeAge Pro 2013, R1.0) was used for the assessment of 
cost-effectiveness of the interventions. Cost of task-shifting was also analysed. A simple 
sensitivity analyses was conducted to examine the robustness of the study findings. 
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Study population and setting 
The analysis included participants of the STRIVE study. The study population of the STRIVE 
study included emergency department patients with substance use problems in the Western Cape 
province of South Africa. The study sample was patients attending the emergency departments of 
Khayelitsha Site B community health centre, Khayelitsha district hospital and Elsies River 
community clinic. The Western Cape province has the highest lifetime prevalence of substance 
use disorders in South Africa with a prevalence of 20.6 compared to the national level of 13.3 
[11]. As at 2011, the unemployment rate was 21.4% in the province [30]; 23.96% in Elsies River 
[31] and 38.02% in Khayelitsha [32]. Both Khayelitsha and Elsies River have high rates of crime 
and violence.  
Screening and recruitment 
Details of screening and assessments are explained in detail elsewhere (Sorsdahl et al, 
unpublished observation). Briefly, 2736 consented patients were screened with the ASSIST for 
substance use by peer counsellors whilst they waited to be attended to by doctors. The ASSIST 
has been proven to be effective in identifying substance users across different substances and 
different settings [33]. Based on their ASSIST score patients were classified as low, moderate or 
high risk for health and other problems due to their pattern of substance use. 531 patients 
screened positive for moderate to high risk of substance use out of the total of 2736 patients 
screened.  110 patients were assigned to the control group, 113 patients were assigned to the MI 
only intervention group and 112 to the MI with PST intervention group. Patients at high risk 
were also referred for specialised treatment whilst those at low risk were excluded from the study 
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[Sorsdahl et al, unpublished observation]. The follow-up rate for the entire study sample was 
54% (n=182). A patient flow chat is presented in figure 1.  
In addition to patient’s level of substance use measured by their ASSIST score, their depressive 
symptoms were also assessed at baseline with the Centre for Epidemiological Studies Depression 
Scale (CES-D). This measured common symptoms of depression based on 20 self-rated items. 
Patients also completed a questionnaire to assess their substance related injuries, violence and 
interaction with the police in the three months preceding the study. The ASSIST and the other 
assessments were re-administered during a three months follow-up to determine the effectiveness 
of the interventions [Sorsdahl et al, unpublished observation]. 
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Source: adapted from the STRIVE study 
2205 patients screened negative (were 
at low /no risk of substance use) 
335 patients consented and 
were randomised 
113 patients randomised into intervention 
group (MI) 
 All received the full intervention 
110 patients randomised into 
control group 
112 were randomised into intervention group (MI 
with PST).  
87 attended PST sessions in addition to the MI (65 
attended four PST sessions; 4 attended three PST 
sessions; 8 attended two PST sessions; 10 attended 
one PST session) 
43 lost to follow-up (could not be located) 
Lost to follow-up (n=44) 
22 discontinued intervention; 3 were admitted into 
tertiary care; 19 could not be located  
46 analysed 
70 analysed 
44 Lost to follow-up (could 
not be located)  
531 patients screened positive (were at 
moderate/high risk of substance use) 
196 were not randomised 
104 refused to participate; 88 excluded for no 
contact details; 4 did not return for 
randomisation after receiving medical 
treatment 
66 analysed 
2736 patients screened for substance use 
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Peer counsellors 
The peer counsellors used for the study were recruited from the study areas. They either had 
tertiary level education (bachelors) or equivalent knowledge and were trained specifically to 
screen and offer the interventions for the purpose of the study [Sorsdahl et al, unpublished 
observation]. In all, they had 45 hours of training from a certified trainer; 25 hours on MI 
training, 12 hours on PST training and 8 hours on screening, including training on substance use 
and risks and research ethics. In addition to being trained, the peer counsellors also had biweekly 
fidelity checks (supervision and debriefing sessions) throughout the study period with a clinical 
psychologist to ensure the fidelity of the interventions.  
Description of interventions 
MI intervention 
Patients randomised into the MI group received only one session of MI after screening and 
baseline assessment. This intervention has been proven to be effective in reducing substance use 
and related problems [33]. The intervention lasted about 30 minutes per patient. Patients received 
substance use risk cards which provided feedback on their level of risk after screening. It also 
provided information on the problems/risks associated with the use of each of the substances 
they use as well as local telephone contacts of SANCA (a substance use centre), the South 
African Depression and Anxiety group and other emergency helplines like the suicide helpline. 
They were also handed a fact sheet on alcohol and illicit drugs. The fact sheet provided basic 
information on alcohol consumption and why people should or should not use illicit drugs. It also 
had the local telephone contacts on the substance use risk card. During the intervention, the peer 
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counsellors talked about substance use, provided feedback on patient’s level of risk based on 
their ASSIST scores on substance use and advised patients on their substance use pattern and the 
need to change in order to minimise their health and other risks especially risk of injury. Through 
a motivational interviewing approach, they also boosted patient’s motivation and willingness to 
change [Sorsdahl et al, unpublished observation].   
MI with PST intervention 
Patients assigned to this intervention group received the same MI intervention discussed above in 
addition to four sessions of PST, provided one week apart from each other [Sorsdahl et al, 
unpublished observation]. PST was designed to provide patients with problem solving and 
coping skills to help them deal with psychological disorders and cope effectively with the stress 
of life. It equips patients with different ways of dealing with a problem and the skill to select the 
most efficient solution [34, 35]. 
The first PST session lasted about 60 minutes and the three other sessions lasted about an 
average of 40 minutes each. During these sessions the peer counsellor worked together with the 
patient to ascertain problems in the patient’s life, during which time the counsellor taught the 
patient how to deal with those problems using structured PST strategies.  A PST booklet was 
used for these sessions and it also contained homework for each session aimed at providing 
patients the chance to practice their problem solving skills in real world situations [Sorsdahl et al, 
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Control  
Patients in this group were given the alcohol and illicit drugs fact sheet without any form of 
intervention during the study. For ethical reasons, they were administered the MI intervention at 
the three months follow-up [Sorsdahl et al, unpublished observation]. 
Costs  
Costs were analysed from a provider and societal perspective. They comprised of both recurrent 
and capital costs, grouped into the cost of screening, intervention, cost of emergency department 
visit and general costs of the intervention. Provider costs were sourced from the project manager 
of the STRIVE study and the expenditure records of the health facilities through the Department 
of Health of the Western Cape Province. Prices were based on 2012/2013 market prices where 
appropriate. Costs to patients were extracted from the questionnaires administered to patients at 
the three months follow up. All costs were calculated and presented in South African rand. Costs 
were reported as average cost per patient. This was calculated as total costs divided by the 
number of patients who screened positive for risky substance use (in the case of screening) and 
the number of patients in an intervention group (in the case of the interventions).   
Estimation of capital costs 
These were made up of the cost of counsellor’s training, room space and furniture used within 
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Cost of room and furniture 
Screening and the interventions were administered in a private room in the emergency 
departments. Cost of room space was estimated based on the price index for new buildings in 
South Africa [36]. Cost of furniture was estimated based on their market prices. It was assumed 
that the useful life for furniture and the rooms used were 5 and 20 years respectively. Capital 
costs were then annuitised using a 3% discount rate [37]. 3% was chosen in order to facilitate 
comparability with other cost-effectiveness analyses. 75% of the annual costs were used in the 
analysis based on the length of the study (which took place over three-quarters of a year). Total 
costs were proportionally allocated to screening, MI and the MI with PST interventions based on 
the number of sessions undertaken in each of these activities.  
Cost of peer counsellors’ training 
Total cost of counsellors training was estimated as the cost of the training materials, room space, 
and the salary of the trainer. Retraining for peer counsellors was assumed to be within the next 
three years. Calculation for annuitisation was the same as described above for furniture and room 
space. Total costs were proportionally allocated to screening and the intervention groups based 
on the number of hours used in training for those activities. Cost per peer counsellor was 
calculated as the total cost divided by the number of peer counsellors.  
Estimation of Recurrent costs 
These costs included the cost of peer counsellor’s time, costs of materials used for screening and 
the interventions (cost of the substance use risk cards, PST booklets, alcohol and illicit drugs fact 
sheets, stationaries), screeners, overheads (cost of emergency department visits), and cost of 
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fidelity checks (cost of tapes for fidelity checks, cost of clinical psychologists for fidelity checks 
and the cost of checking the tapes after each session of fidelity checks).  
Cost of counsellor’s time 
Total salary paid to a peer counsellor was divided by the total number of minutes used for 
screening and the interventions to generate the cost per minute. The total cost of each activity 
was calculated as the product of the cost per minute and the total number of minutes for the 
activity. It was assumed that this also covered the cost of time the peer counsellor was not seeing 
any patient. Cost per patient was estimated as the total costs divided by the number of patients 
receiving the interventions. Cost of time for baseline and follow-up assessments were considered 
as research costs and were therefore ignored. 
Overheads 
These included the general operating costs required to run the emergency departments, and were 
allocated per emergency department visit using routine facility visit statistics. They were mostly 
administrative costs, costs of medical and non-medical staff, utilities, and other operational costs 
of the health facilities. Total costs of overheads were estimated for all three facilities over the 
study period. Average cost per patient was estimated as the total costs divided by the total 
number of patient who visited the emergency departments during the study period. 
Cost of materials 
Costs of materials used for screening and the interventions included the cost of the substance use 
risk cards, PST booklets, alcohol and illicit drugs fact sheets, screeners and other stationary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
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Costs per patient for the risk cards (used for the MI), PST booklets, substance-use facts sheets 
and screeners were based on the unit costs provided by the project manager for the STRIVE 
study. For the other stationaries used, costs were based on their market prices.  
Cost of fidelity checks 
Cost of fidelity checks included the cost of tape recorders used for the recording the fidelity 
check sessions, salary of clinical psychologists for checking the tapes and for undertaking the 
exercise with the peer counsellors. Total costs were calculated as the sum of all those costs over 
the study period. Costs were allocated proportionally to screening and the intervention groups in 
a similar way as cost of peer counsellor’s training was allocated.  
Cost of screening 
This was made up of cost of screeners, stationary, cost of peer counsellor’s time and the share of 
capital costs and cost of fidelity checks allocated to screening.  
Cost of MI only intervention 
The direct costs of the MI only intervention included cost of the substance use risk cards, alcohol 
and illicit drugs fact sheets, other stationary used, peer counsellor’s time for the delivery of the 
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Cost of the MI with PST intervention 
This included both provider’s costs and costs to patients. Provider’s costs of the intervention 
were the cost of the PST booklets (which also included the substance use risk cards), peer 
counsellor’s time for the delivery of the interventions, substance use information sheet, other 
stationary used, capital costs and cost of fidelity checks apportioned to the MI with PST 
intervention.  
Costs to patients 
Cost to patients for participating in the intervention was basically the transportation costs 
incurred by participants for travelling to the facilities to attend their PST sessions. Productivity 
losses in terms of salary loss, cost of care takers and other non-health care costs to patients as a 
result of their participation in the intervention were excluded from the analysis because the 
patients indicated that they did not incur these costs or losses. Patients reported their cost of 
transportation for a PST session during the follow-up session. Not all patients incurred this cost 
because many walked; those who incurred these costs reported costs ranging between R 14 to R 
25. To include this cost in the costing analysis, the mean cost of transportation was calculated as
the sum of the costs reported by each participant divided by the total number of participants who 
answered this question (thereby including those who had incurred zero cost in this calculation). 
This was multiplied by the number of PST sessions attended to get the total cost of transportation 
incurred for attending the PST sessions. Average cost of transportation per patient for attending 
PST sessions was estimated as the total cost divided by the number of participants who were in 
the MI with PST intervention group. There were no costs to patients for participation in the MI 
and control groups because they received their intervention whilst seeking health care in the 
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emergency departments. In contrast to those in the MI with PST intervention group, they did not 
have to attend the facilities specifically for any intervention.  
Analysis 
Effectiveness Analysis 
Reduction in patient’s ASSIST score (which measure their substance use), depressive symptoms 
and verbal arguments were used as the measures of effectiveness of the interventions. 
Effectiveness, measured as the mean point difference between assessments at baseline and at 3 
months follow-up was estimated with paired-samples t-test. Difference between the groups was 
analysed with univariate ANCOVAs. Pre-treatment scores were used as the covariate [Sorsdahl 
et al, unpublished observation].  
Cost-effectiveness analysis 
A decision tree model was created to assess the cost-effectiveness of the interventions. A 
decision tree is a flow chart that illustrates the structure of a problem. It integrates the costs and 
outcomes of the different ways or strategies of dealing with the problem. Decision trees are 
useful when modelling interventions that lead to outcomes in the short-term (example, short term 
screening programs, interventions for acute health care problems, etc.). They are also suitable for 
economic evaluations that consist of intermediate outcomes [38]. They are generally useful for 
modelling problems that have simple scenarios that are relatively less complicated.  
For this study, the model, as depicted in figure 3, was built to compare the costs and 
effectiveness of the interventions with the status quo of no intervention. The costs and 
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effectiveness of the interventions estimated from the STRIVE study were used to populate the 
model. In the model, patients were allocated to the intervention groups (MI only, MI with PST 
and status-quo of no intervention) and followed through a series of events to establish the costs 
and outcomes of the interventions. The model assigned costs and outcomes to the different 
events. Patients were tracked through the model depending on whether they screened positive or 
negative to substance use. Patients who screened positive were further followed based on 
whether they gave consent for the intervention, refused it or were excluded for not having 
contact details for follow-up. Patients in the MI with PST intervention group were again 
followed based on whether they dropped out of the intervention or not and the number of PST 
sessions they attended. The proportions (table 1) and assumptions (table 2) used in the decision 
tree model were based on the outcome of the STRIVE study.  
The model estimated the incremental cost effectiveness ratios (ICERs) of the interventions. 
ICER is the ratio of additional costs to additional effect – comparing each more costly 
intervention to the one directly preceding it [37]. Cost of emergency department visits was the 
only cost incurred in the status-quo situation. Cost of intervention was therefore considered to be 
zero (0) because in the status-quo situation, no form of intervention was offered to patients with 
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         Table 1: The proportions that drove patient’s pathways in the model 
Event Proportions used  
Screened negative 0.81 
Screened positive 0.19 
Gave consent to receive interventions 0.63 
Refused the interventions 0.20 
Excluded from interventions for some reason 0.17 
Attended all four PST sessions 0.58 
Did not attend all PST sessions 0.39 
Referred for tertiary care 
 
0.03 
Proportions who did not attend all PST sessions  
Did not attend any PST session 0.50 
Attended one PST session 0.23 
Attended two PST sessions 0.18 
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       Table 2: Model assumptions 
Assumptions 
Patients who screened negative for substance misuse were assigned a zero (0) outcome 
which can be interpreted to mean that no improvement in outcome was achieved. The 
outcome measures used in the study were the mean point difference between baseline 
and follow-up. Those who screened negative did not record follow-up values.  
Patients who tested positive for substance misuse but refused the intervention, as well 
as those excluded from the study after being screened, were assigned the outcomes 
recorded for those in the control group. 
Patients who dropped out of the MI with PST intervention group were assigned the 
same outcome measures as those who received the MI only intervention because that 
was all the intervention they received. 
Patients who did not attend all PST sessions in the MI with PST group were allocated 
the same outcomes as those who attended all the sessions. This was because the study 
did not record separate outcomes for them. It was therefore assumed that the 
intervention had the same impact on them.   
 
Cost of task-shifting 
In addition to the cost-effectiveness analysis, the cost of using peer counsellors instead of clinical 
psychologists was also analysed. This included the total cost of peer counsellor’s training, 
salaries and fidelity checks. Both total costs and costs per peer counsellor were analysed. Total 
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cost was estimated as the sum of all the costs over the study period. Because the cost recorded 
was the total for all the five peer counsellors used in the study, average cost per peer counsellor 
was estimated by dividing the total cost by the total number of peer counsellors used in the study. 
Cost of peer counsellor’s training included in this section of the analysis was the full cost and not 
based on the annuitised cost as was estimated under capital cost. The reason was to incorporate 
the full cost of training. 
Sensitivity Analysis   
Simple sensitivity analysis was conducted to test the robustness of the study findings [39]. The 
proportion of patients that screened positive was about 19% of the total screened and this was 
increased to see what the situation would be like in a case of higher prevalence. In the study, not 
all the patients in the MI with PST intervention group completed the intervention. In the 
sensitivity analysis, the percentage that completed the intervention was increased. The main cost 
drivers of the interventions were also varied to see their impact on the study results.  
Results 
Baseline characteristics 
65% (n=218) of the study participants included in the STRIVE study were men. Their ages 
ranged between 18 to 75 years with the average age being 28 years. 72.2% of the people attended 
the emergency department for treatment of their injuries. 76.5% (n=185) of these injuries were as 
a result of violent assaults and 59.2% (n=197) of the injured patients were under the influence of 
psychoactive substances when they attended the emergency departments. Alcohol was the most 
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common substance used (n=286, 85%), followed by cannabis (n=24, 7%) and methamphetamine 
(n=20, 6%) [Sorsdahl et al, unpublished observation]. 
Effectiveness 
The effectiveness data from the STRIVE study showed that both interventions were more 
efficacious in all three outcome measures than the control group of no intervention even though 
all three groups recorded some reduction (i.e. improvement) in their outcome measures at 3 
months follow-up. The mean effectiveness of the different groups is presented in table 3. A 
significant number of participants who received the MI with PST intervention recorded better 
outcomes compared to those who received the MI only intervention with respect to substance use 
and depressive symptoms. Their mean ASSIST score reduced from 19.20 (SD=6.59) at baseline 
to 7.4 (SD=5.9) at three months follow-up and their mean depressive symptoms measured by the 
CES-D reduced from 26.0 (SD=6.85) at baseline to 12.91 (SD=5.93) at 3 months follow-up. The 
mean ASSIST score for those in the MI only group reduced from 20.33 (SD=6.71) at baseline to 
12.31 (SD=7.87) at three months follow-up whilst their mean depressive symptoms measured by 
the CES-D reduced from 23.28 (SD=7.84) at baseline to 16.92 (SD=7.85) at 3 months follow-up. 
Difference between groups was significant at a p-value<0.001. The MI only intervention was 
more efficacious in reducing the frequency of verbal arguments [mean reduction from 0.53 
(SD=0.94) at baseline to 0.23 (SD=0.46) at 3 months follow-up] compared to the MI with PST 
intervention [mean reduction from 0.83 (SD=1.34) at baseline to 0.65 (SD=1.2) at 3 months 
follow-up]. This was significant at a p-value of 0.004 [Sorsdahl et al, unpublished observation]. 
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Table 3: Mean effectiveness of interventions (expressed as difference in these measures 
between baseline and three-month follow up) 
Intervention Mean effectiveness 
ASSIST score Depression Verbal argument 
Status-quo 7.01 1.5 0.01 
MI 8.01 6.23 0.3 
MI with PST 11.8 13.08 0.17 
Costs 
The cost per patient refers to the full cost of each intervention if delivered in its entirety (e.g. 
without any loss to follow up).  The cost of screening was R 83.48, the direct cost of the MI only 
intervention was R 317.73 and the direct cost of the MI with PST intervention was R 689.79 
(provider cost=R 631.20; patient cost=R 58.59). The average cost of an emergency department 
visit per patient for all three facilities used was R 378.68 (table 4). The main cost drivers of the 
direct cost of the interventions and screening per patient were costs of fidelity checks (22.42% of 
screening cost; 86.48% of MI only cost; 61.12% of MI with PST intervention cost) and cost of 
counsellor’s time per patient (69.90% of screening cost; 10.69% of MI only intervention cost; 
25.5% of MI with PST intervention cost). 
The total cost per patient in each intervention group if delivered in full was estimated as the 
direct cost of the intervention, cost of screening and the average cost of emergency department 
visit. All put together, the average cost per patient was R 779.89 for the MI only intervention and 
R 1093.36 for MI with PST intervention (table 4). Cost of emergency department visit accounted 
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for the highest percentage (48.56%) of the overall cost of MI only intervention whilst the direct 
cost of the MI with PST intervention accounted for the highest percentage (59.88%) of the MI 
with PST intervention. Cost of screening contributed the lowest percentage to all the 
interventions (figure 2).  
Table 4: Cost per patient 
Cost variables  Average Cost per patient 
Provider Costs  MI only intervention   MI with PST 
intervention 
 Cost of screening  R 83.48  R 83.48 
 Cost of the intervention  R 317.73  R 631.20 
 Cost of emergency department visits  R 378.68  R 378.68 
Sub total  R 779.89  R 1093.36 
Patient Costs     
 Cost of transportation  N/A  R 58.59 
Total   R 682.10  R 1151.95 
Note: N/A means the estimation is not applicable in that particular situation 
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    Figure 2: Distribution of cost per patient for each intervention 
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Cost-effectiveness analysis 
Cost-effectiveness was assessed within the decision tree model depicted in Figure 3. In assessing 
cost-effectiveness, the analysis took into account patients that were lost to follow-up, excluded or 
refused the intervention. Because of this, both the costs and the effectiveness calculated are 
lower than the cost per patient and the effectiveness reported above. But, as before, both 
interventions were more costly and more effective than the status quo of no intervention. The MI 
with PST intervention was more costly than the MI only intervention. It was also more effective 
with respect to reduction in patient’s ASSIST score and depressive symptoms, leading to ICERs 
of R 340.66 and R 133.46 for mean reduction in patient’s ASSIST score and depressive 
symptoms respectively. For these outcome measures, the MI intervention was eliminated through 
extended dominance. This implied that a combination of no intervention and MI with PST 
intervention would be more cost-effective than administering only the MI intervention to 
patients. The MI only intervention was more effective with respect to reduction in verbal 
argument, leading to an ICER of R 3500.48 per patient. The MI with PST intervention was more 
costly and less effective with respect to verbal argument and was eliminated through absolute 
dominance (table 5).  
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Figure 3: Output of the decision tree model. 
* outcome measures= effectiveness values for patient’s ASSIST score, depression and verbal arguments; ED=emergency
department
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Incremental cost effectiveness ratios 
(ICERs)  [ΔC/ΔE] 
Interventions *AS *DP *VA *AS *DP *VA *AS *DP *VA
Status quo (no 
intervention) 
R 378.68 N/A 1.33 0.29 0 N/A N/A N/A N/A N/A N/A 
MI only R 500.19 R 121.51 1.45 0.86 0.04 0.12 0.57 0.03 #Dominated #Dominated 3500.48 
MI with PST R 539.23 R 160.55 1.8 1.49 0.02 0.47 1.2 -0.01 340.66 133.46 †Dominated 
Note: *AS= ASSIST score; DP= depression; VA= verbal arguments; ΔC = change in cost compared to status quo; ΔE= change in effectiveness 
compared to status quo; MI= motivational interviewing; PST=problem solving therapy; R = South African rands; N/A means the estimation was not 
applicable in that particular situation;  #Dominated through extended dominance (the MI with PST intervention had a lower ICER than the MI only 
intervention with respect to the outcome measures in question); †Dominated through absolute dominance (the MI with PST intervention was more 
costly and less effective compared to the MI only intervention and so was dominated by the MI only intervention).  
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Cost of task-shifting 
Total cost of task-shifting was R 561 950 for all five peer counsellors used in the study and        
R 112 390 for each peer counsellor. Cost of fidelity checks contributed to 49.73% of the total 
costs whilst the cost of peer counsellor’s salary contributed to 48.05% of the cost. Cost of 
training accounted for only a 2.22% of the total cost (table 6). 
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Table 6: Cost description of task-shifting 
Cost items 
Costs per month 
Total costs over study period (9 
months)  
Contribution of 
cost item to total 
cost (%) 
Cost per peer 
counsellor  
Cost for all five 
peer counsellors 
Cost per peer 
counsellor  
Cost for all five 
peer counsellors 
Cost of peer counsellor’s 
training N/A N/A R 2 500 R 12 500 2.22% 
Cost of fidelity checks R 6 210 R 31 050 R 55 890 R 279 450 49.73% 
Salary paid to peer counsellors R 6 000 R 30 000 R 54 000 R 270 000 48.05% 
Total R 12 487.78 R 62 438.89 R 112 390 R 561 950 100% 
Note: N/A means the estimation was not applicable in that particular situation 
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Sensitivity analysis 
In the initial analysis which was based on study findings, 19% of patients screened positive for 
moderate and high risk of substance use. In the sensitivity analysis this was varied from 1% to 
50%. This resulted in an increase in the costs and effectiveness of the interventions. While the 
ICER for the MI intervention (for the ASSIST score and depressive symptoms) continued to be 
higher than that for MI with PST (and hence would be eliminated through extended dominance) 
the MI intervention did improve its cost-effectiveness as the proportion of patients that screened 
positive increased. For verbal argument on the other hand, the MI with PST intervention was still 
dominated by the MI only intervention (table 7).  
Increasing the proportion of patients who completed the MI with PST intervention from 58% to 
100% led to an increase in the costs and effectiveness of the intervention with respect to patient’s 
ASSIST score and depressive symptoms (table 9). The intervention still had lower ICER than the 
MI only intervention. The effectiveness of the intervention in reducing verbal argument on the 
other hand decreased as more patients participated in the full intervention. The intervention was 
still dominated by the other interventions as was reported in the initial analysis. 
Cost of fidelity checks was identified as one of the main cost drivers of the direct cost of the 
interventions. 5%, 10% and 50% reduction in the cost led to some reduction in the costs of 
screening and the interventions (table 8). Cost of peer counsellor’s time was identified as another 
cost driver. An analysis of the working capacity of the peer counsellors showed that they had 
enough excess capacity to see more patients. A simple analysis showed that given the number of 
minutes used for screening and the interventions, the peer counsellors could screen 8780 patients 
and offer each of the interventions to 852 people (if 1716 screened positive  based on the 19% 
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used in the study). This could lead to reduction in the cost of counsellor’s time per patient. At the 
moment, the counsellor’s utilised only 16% of their time seeing patients.  
114 | P a g e
Table 7: Sensitivity analysis: Varying the proportion of patients who screened positive 
% screening 
positive 
Intervention Costs Incremental costs Effectiveness Incremental 
effectiveness 
ICERs 
*AS *DP *VA *AS *DP *VA *AS *DP *VA
Status quo R 378.68 0.07 0.02 0.000 
1% MI only R 464.16 R 85.48 0.08 0.05 0.002 0.01 0.03 0.002 #dominated #dominated 46788.01 
MI with PST R 466.22 R 2.05 0.09 0.08 0.001 0.02 0.03 -0.001 3529.02 1382.55 †dominated 
Status quo R 378.68 1.22 0.26 0.002 
17% MI only R 496.86 R 118.18 1.32 0.78 0.033 0.11 0.52 0.032 #dominated #dominated 3731.72 
MI with PST R 532.47 R 35.61 1.65 1.36 0.022 0.32 0.58 -0.011 357.69 140.13 †dominated 
Status quo R 378.68 2.36 0.51 0.003 
34% MI only R 529.55 R 150.87 2.57 1.52 0.065 0.21 1.01 0.062 #dominated #dominated 2452.82 
MI with PST R 598.72 R 69.17 3.20 2.64 0.044 0.62 1.12 -0.021 263.49 103.23 †dominated 
Status quo R 378.68 3.51 0.75 0.005 
50% MI only R 562.24 R 183.56 3.82 2.26 0.096 0.32 1.51 0.091 #dominated #dominated 2009.47 
MI with PST R 664.97 R 102.72 4.75 3.92 0.065 0.93 1.66 -0.032 230.83 90.43 †dominated 
*AS= ASSIST score; DP= depression; VA= verbal arguments; †dominated through absolute dominance (explained above);
#dominated through extended dominance (explained above)
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  Table 8: Sensitivity analysis: Percentage reduction in cost of fidelity checks  




Cost of fidelity checks 
(R) 
 
Cost of Screening 
(R) 
 
MI intervention  MI with PST intervention 
   Direct cost of intervention 
 (R) 
 Direct cost of intervention  
(R) 
Initial analysis 55890  83.48  317.73  689.79 
%  reduction in cost        
5% 53095.5  82.54  303.99  668.71 
10% 50301  81.61  290.26  647.63 
50% 27945  74.12  180.34  478.99 
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Table 9: Sensitivity analysis: Increasing the proportion of patients who completed the MI with PST intervention 
% completed intervention Interventions Costs Incremental costs Effectiveness Incremental effectiveness ICERs 
*AS *DP *VA *AS *DP *VA *AS *DP *VA 
58%(As used in initial 
analysis) 
Status quo R 378.68 1.33 0.29 0.002 
MI only R 500.19 R 121.51 1.45 0.86 0.037 0.12 0.57 0.035 1015.14 212.37 3500.48
MI with PST R 538.12 R 37.93 1.80 1.49 0.025 0.34 0.62 -0.012 110.01 61.31 †dominated
Status quo R 378.68 1.33 0.29 0.002 
72% MI only R 500.19 R 121.51 1.45 0.86 0.037 0.12 0.57 0.035 1015.14 212.37 3500.48
MI with PST R 543.28 R 43.09 1.83 1.53 0.024 0.38 0.68 -0.013 114.43 63.78 †dominated
Status quo R 378.68 1.33 0.29 0.002 
86% MI only R 500.19 R 121.51 1.45 0.86 0.037 0.12 0.57 0.035 1015.14 212.37 3500.48
MI with PST R 548.44 R 48.24 1.86 1.59 0.023 0.41 0.73 -0.014 118.16 65.86 †dominated
Status quo R 378.68 1.33 0.29 0.002 
100% MI only R 500.19 R 121.51 1.45 0.86 0.037 0.12 0.57 0.035 1015.14 212.37 3500.48
MI with PST R 553.59 R 53.40 1.89 1.65 0.022 0.44 0.79 -0.015 121.35 67.64 †dominated
*AS= ASSIST score; DP= depression; VA= verbal arguments; †Dominated through absolute dominance (explained above); R= South African
rand.
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Discussion 
The study examined the cost-effectiveness of two brief interventions delivered in emergency 
departments by peer counsellors, with a no intervention comparator. The cost-effectiveness 
results suggested that a combination of no intervention with the MI with PST intervention 
would be more cost-effective than the MI only intervention with an ICER of R 340.66 for a 
mean point reduction in a patient’s ASSIST score and an ICER of R 133.46 for a mean point 
reduction in depressive symptoms. For verbal argument MI only intervention could be the 
preferred intervention compared to the MI with PST intervention given that it was more 
effective and less costly. 
 The intervention related costs (screening and the direct costs of the interventions) 
contributed about half of the total costs of the interventions (35% for the MI only intervention 
and 56% for the MI with PST intervention). Cost of emergency department visit (overhead 
costs – administrative and operational costs of the facilities) accounted for the rest of the 
costs. For the MI with PST intervention, the costs to patients contributed less than 10% of the 
cost of the intervention. About 90% of the cost was therefore borne by the provider. 
The study also highlighted the fact that, at relatively minimal costs, it was possible to employ 
and train people without any prior medical or mental health skills to screen and effectively 
deliver the brief interventions in emergency departments.  Expert knowledge shows that the 
cost of employing a trained clinical psychologist for these activities could cost about 5 times 
more than the salary of a peer-counsellor. 
The results of this study support findings from other studies that brief interventions for 
substance use in emergency departments can be cost-effective [27, 28]. The inclusion of a 
combined MI with PST intervention in the analysis differentiates the current study from the 
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other published studies. Even though the analysis of brief MI is common, the same cannot be 
said about PST, let alone a combination of the two. This study has therefore shown that 
administering a combined intervention of MI with PST can be a better option than just the MI 
only intervention, especially if the aim is to reduce patient’s substance use and depressive 
symptoms.  
Another difference in this study was the presentation of a cost description of task-shifting. 
Even though a number of studies have used non-medical and/or non- traditional mental health 
workers for screening and the delivery of brief interventions for substance use [26, 27], the 
cost of this is usually incorporated in the cost-effectiveness analysis. A separate cost 
description of task-shifting gives a clear estimate of how much it costs to train and employ 
these non-traditional medical and/or mental health workers. It can also provide a better guide 
to decision makers in their cost comparison and decision making about what kind of 
personnel to use for these interventions. 
Despite the promising results of the cost-effectiveness analysis, the ICERs presented cannot 
form the only basis upon which implementation decisions can be made. In effect, as 
suggested by Birch and Gafni [40], a consideration of the budgetary limitations, the total cost 
of both interventions, the number of people at risk of harmful substance use, those in need of 
the interventions, the general health needs of the population as against available health budget 
among other things must be considered in the decision making to ensure efficient and 
equitable allocation of resources. 
The results of the cost-effectiveness analysis showed that in order to reduce patient’s ASSIST 
score and depressive symptoms, it would be more cost-effective to target the MI with PST 
intervention to settings where there would be a relatively high likelihood of finding patients 
with alcohol and substance misuse. However, targeting the intervention in this manner could 
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lead to some ethical issues. For example, would it be ethical to provide the intervention in 
certain high risk settings while providing only psycho-educational material elsewhere; under 
what conditions would such decisions be made and on what bases? 
One of the limitations to the study was its inability to estimate the cost of productivity losses, 
thus inhibiting the calculation of the full cost to patients. Productivity losses were not 
included because none were reported by patients. Most of the participants were unemployed. 
It was difficult to estimate actual or potential productivity losses to them because there was 
not enough information. 31 of the participants in the MI with PST intervention group who 
showed up for the 3 months follow-up were unemployed. Of those who were employed, only 
four took time off work to attend their sessions and only one out of these reported losing 
some salary even though no amount was stated.   
The study also suffered from high rate of loss to follow-up, especially in the MI with PST 
intervention group. This may have masked the estimated full costs and effectiveness of the 
interventions, thereby introducing a potential bias in the cost-effectiveness analysis. This 
shortcoming was however addressed in the sensitivity analysis that indicated that cost-
effectiveness would be enhanced if initial loss to follow up were reduced. A shortcoming that 
could not be addressed, however, was the assumption of equal effectiveness for all who 
received one, two, three or four PST sessions. In reality, effectiveness might be higher if 
patients received all four sessions.  
The peer counsellors posted to the facilities could not work fully due to lack of office space 
in some of the facilities and lack of cordial relationship between them and the staff in the 
facilities. This may have been one of the main reasons for their high excess capacity. If the 
conditions were more favourable they could have been able to see more patients than they 
did.   
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It would have been beneficial to do a full economic evaluation of task-shifting by comparing 
the costs and effectiveness of using peer counsellors and clinically trained psychologists or 
other medical/mental health workers. However, this could not be accomplished in this study 
because the relevant information on the latter group of workers was unavailable and beyond 
the scope of the current analysis. The study also could not include the long term economic 
costs of the interventions especially its impact on long term utilisation of emergency 
department services which would hopefully be reduced through lowered substance misuse in 
communities. This could have thrown more light on the long term benefits of the 
interventions from the provider’s perspective. Reduced substance use could also be valuable 
for the wellbeing of communities for instance in terms of reduced violence and crimes. 
Future studies could look at these issues. Such a study will provide more information on the 
full economic costs and benefits.  
Conclusion 
This study has illustrated that the use of peer counsellors for screening and the administration 
of a combined brief intervention of MI and PST to substance users in emergency departments 
can be cost-effective in reducing substance use and depressive symptoms. In a country like 
South Africa where substance use is high and resources to deal with the problem are limited 
both in terms of finance and well qualified human resources, introduction of interventions 
like this can be useful in minimising substance use and related problems at a relatively 
minimal cost.   Despite the encouraging results presented in this study, a future study that 
would include the long term utilisation of the emergency departments, and also compare the 
costs and effects of using peer counsellors and clinical psychologist and/or other medical or 
mental health workers could add to decision-making. 
 
 
121 | P a g e  
 
Competing interests 
The author(s) declare that they have no competing interests. 
Acknowledgement  
Associate Professor Susan Cleary and the members of the STRIVE study, especially Dr. 
Katherine Sorsdahl (PhD) are acknowledged for their assistance and guidance during the 
work. The department of Health of the Western Cape Province is also acknowledged for 













122 | P a g e  
 
References  
1. World Health Organization. ATLAS on substance use (2010): Resources for the 
prevention and treatment of substance use disorders. Geneva: World Health 
Organization. 2010,137.  
2. Atkinson A, Anderson Z, Hughes K, Bellis M, Sumnall H, Syed Q: Interpersonal 
violence and illicit drugs. Liverpool: Centre for Public Health, Liverpool John Moores 
University. 2009.  
3. Callaghan RC, Gatley JM, Veldhuizen S, Lev-Ran S, Mann R, Asbridge M: Alcohol-or 
drug-use disorders and motor vehicle accident mortality: A retrospective cohort study. 
Accident Analysis & Prevention. 2013.  
4. Cherpitel CJ: Substance use, injury, and risk-­‐taking dispositions in the general 
population. Alcoholism: Clinical and Experimental Research. 1999,23(1):121-6.  
5. Brysiewicz P: Trauma in south africa. Int J Trauma Nurs. 2001,7(4):129-32.  
6. Hungerford DW (a): Recommendations for trauma centers to improve screening, brief 
intervention, and referral to treatment for substance use disorders. The Journal of 
Trauma and Acute Care Surgery. 2005,59(3):S37-42.  
7. Hungerford DW (b): Interventions in trauma centers for substance use disorders: New 
insights on an old malady. The Journal of Trauma and Acute Care Surgery. 
2005,59(3):S10-7.  
8. Parry CD, Bhana A, Myers B, Plüddemann A, Flisher AJ, Peden MM, Morojele, N.K: 
Alcohol use in south africa: Findings from the South African Community Epidemiology 
123 | P a g e
Network on Drug Use (SACENDU) project. Journal of Studies on Alcohol and Drugs. 
2002,63(4):430.  
9. Soderstrom CA: Session 2: Substance-abuse interventions-setting the stage for
discussion. The Journal of Trauma and Acute Care Surgery. 2005,59(3):S77-9. 
10. Pasche S, Myers B: Substance misuse trends in South Africa. Hum Psychopharmacol
Clin Exp. 2012,27(3):338-41. 
11. Herman AA, Stein DJ, Seedat S, Heeringa SG, Moomal H, Williams DR: The South
African stress and health (SASH) study: 12-month and lifetime prevalence of common 
mental disorders. SAMJ: South African Medical Journal. 2009,99(5):339-44.  
12. Kessler, R.C., Angermeyer, M., Anthony, J.C., De Graaf, R., Demyttenaere, K., Gasquet,
I., De Girolamo, G., Gluzman, S., Gureje, O., Haro, J.M: Lifetime prevalence and age-of-
onset distributions of mental disorders in the World Health Organization's world 
mental health survey initiative. World Psychiatry. 2007,6(3):168.  
13. Temmingh H, Myers B: Clinical treatment of substance use disorders in South
Africa. Substance use and abuse in South Africa. 2012,329-66. 
14. Myers B, Louw J, Pasche S: Inequitable access to substance abuse treatment services
in Cape Town, South Africa. Subst Abuse Treat Prev Policy. 2010,5:28. 
15. Kumar S, Malhotra A: Brief interventions in substance abuse. Indian journal of
psychiatry. 2000,42(2):172. 
16. Henry-Edwards S, Humeniuk R, Ali R, Monteiro M, Poznyak V: Brief intervention for
substance use: A manual for use in primary care. Draft version. 2003,1. 
 
124 | P a g e  
 
17. Bernstein E, Edwards E, Dorfman D, Heeren T, Bliss C, Bernstein J: Screening and 
brief intervention to reduce marijuana use among youth and young adults in a pediatric 
emergency department. Acad Emerg Med. 2009,16(11):1174-85.  
18. Gentilello LM, Rivara FP, Donovan DM, Jurkovich GJ, Daranciang E, Dunn CW, 
Villaveces, A, Copass, M, Ries, R.R: Alcohol interventions in a trauma center as a means 
of reducing the risk of injury recurrence. Ann Surg. 1999,230(4):473.     
19. McCambridge J, Strang J: The efficacy of single-­‐session motivational interviewing in 
reducing drug consumption and perceptions of drug-­‐related risk and harm among 
young people: Results from a multi-­‐site cluster randomized trial. Addiction. 
2004,99(1):39-52.  
20. Monti PM, Colby SM, Barnett NP, Spirito A, Rohsenow DJ, Myers M, Woolard, R,  
Lewander, W: Brief intervention for harm reduction with alcohol-positive older 
adolescents in a hospital emergency department. J Consult Clin Psychol. 1999,67(6):989.    
21. Babor TF, Kadden RM: Screening and interventions for alcohol and drug problems in 
medical settings: What works? The Journal of Trauma and Acute Care Surgery. 
2005,59(3):S80-7.  
22. Dovlo D: Using mid-level cadres as substitutes for internationally mobile health 
professionals in africa. A desk review. Human Resources for Health. 2004,2(1):7.  
23. Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R: Brief 
motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol 
Depend. 2005,77(1):49-59.  
 
125 | P a g e  
 
24. Myers B, Stein DJ, Mtukushe B, Sorsdahl K: Feasibility and acceptability of screening 
and brief interventions to address alcohol and other drug use among patients presenting 
for emergency services in cape town, South Africa. Advances in preventive medicine. 
2012.  
25. Cowell AJ, Bray JW, Mills MJ, Hinde JM: Conducting economic evaluations of 
screening and brief intervention for hazardous drinking: Methods and evidence to date 
for informing policy. Drug Alcohol Rev. 2010,29(6):623-30.  
26. Cowell AJ, Brown JM, Mills MJ, Bender RH, Wedehase BJ: Cost-effectiveness analysis 
of motivational interviewing with feedback to reduce drinking among a sample of 
college students. Journal of studies on alcohol and drugs. 2012,73(2):226-37.  
27. Kunz FM, French MT, Bazargan-Hejazi S: Cost-effectiveness analysis of a brief 
intervention delivered to problem drinkers presenting at an inner-city hospital 
emergency department. J Stud Alcohol. 2004,65(3):363-70.  
28. Neighbors CJ, Barnett NP, Rohsenow DJ, Colby SM, Monti PM: Cost-effectiveness of a 
motivational lntervention for alcohol-involved youth in a hospital emergency 
department. Journal of studies on alcohol and drugs. 2010,71(3):384.  
29. Barrett B, Byford S, Crawford MJ, Patton R, Drummond C, Henry JA, Touquet, R: Cost-
effectiveness of screening and referral to an alcohol health worker in alcohol misusing 
patients attending an accident and emergency department: A decision-making 
approach. Drug Alcohol Depend. 2006,81(1):47-54.  
 
126 | P a g e  
 
30. Lehohla, P: Statistics South Africa, Census 2011 municipal report, Western Cape. 
[http://www.statssa.gov.za/Census2011/Products/WC_Municipal_Report.pdf]. Assessed 18th 
January 2014 
31. Strategic Development Information and GIS Department (SDI&GIS): City of Cape 
Town - 2011 census suburb, Elsies River. 
[http://www.capetown.gov.za/en/stats/2011CensusSuburbs/2011_Census_CT_Suburb_Elsies
_River_Profile.pdf]. Assessed 18th January 2014 
32. Strategic Development Information and GIS Department (SDI&GIS): City of Cape 
Town -2011 census suburb, Khayelitsha. 
[http://www.capetown.gov.za/en/stats/2011CensusSuburbs/2011_Census_CT_Suburb_Khaye
litsha_Profile.pdf].  Assessed 18th January 2014 
33. Humeniuk R, Henry-Edwards S, Ali R, Poznyak V, Monteiro MG: The alcohol, smoking 
and substance involvement screening test (ASSIST): Manual for use in primary care. 
2010.  
34. D’Zurilla TJ, Nezu AM: Problem-solving therapy. Handbook of cognitive-behavioral 
therapies. 2010,3:197-225.  
35. D'Zurilla TJ, Goldfried MR. Problem solving and behavior modification. J Abnorm 
Psychol. 1971,78(1):107.  
36. Bureau for economic research, University of Stellenbosch: Trends. 2012,35:88. 
[http://www.ber.ac.za/data/2007.aspx]. Assessed March 2013 
37. Drummond MF, Sculpher MJ, Torrance GW: Methods for the economic evaluation of 
health care programs. Oxford university press; 2005.  
 
127 | P a g e  
 
38. Karnon J, Brown J: Selecting a decision model for economic evaluation: A case study 
and review. Health Care Manag Sci. 1998;1(2):133-40.  
39. Briggs AH: Handling the uncertainty in the results of economic evaluation. Office of 
Health Economics; 1995.  










































Providing brief interventions to substance users in 
emergency departments in the Western Cape Province:  
Which brief intervention is more cost-effective? 
The policy brief is based on a study that assessed the cost-effectiveness of two brief interventions, motivational 
interviewing and a combination of motivational interviewing and problem solving therapy, delivered in emergency 
departments by peer counsellors. The study was submitted as an MPH mini dissertation to the Health Economics Unit 
of the Faculty of Health Sciences at the University of Cape Town by Rebecca Dwommoh, under the supervision of 
A/Prof. Susan Cleary. The study was part of a larger project STRIVE [Substance use and Trauma Intervention] which 
assessed the effectiveness of the interventions.   
The project was sponsored by the Department of Health of the Western Cape Province through the Psychiatry 
Department of University of Cape Town 





Substance use disorder has been associated with a high rate of interpersonal violence, 
vehicular accidents and crime in the Western Cape Province and South Africa in general. 
Brief interventions, delivered in different settings including emergency departments, have 
been found to be effective in alleviating the problem of substance use disorder and related 
problems. Estimating the cost-effectiveness of these brief interventions highlights the 
financial implication of their implementation and also ensures efficient allocation of 
resources by comparing costs and effectiveness of the interventions. In the Western Cape, a 
combination of motivational interviewing and problem solving therapy provided in 
emergency departments has been found to be a more cost-effective intervention in reducing 
patients’ substance use and depressive symptoms compared to just motivational interviewing. 
Motivational interviewing is also more cost-effective with respect to reduction in verbal 
arguments. The study also shows that it is feasible to use peer counsellors to screen and 





Substance use disorders account for a number of public health problems which include 
interpersonal violence, road traffic accidents, diseases, injuries and even deaths. In the year 
2000, alcohol-related deaths were 37,000, accounting for 7.1% of total deaths in South Africa 
(Schneider et al, 2007). South Africa has one of the highest rates of substance use disorder in 
the world with a lifetime prevalence of about 13.3% and an estimated life time risk of 17.5%. 
The Western Cape Province has the highest lifetime prevalence rate (20.6% - higher than the 
national rate of 13.3) in the country (Herman et al, 2009; Kessler et al, 2007). These high 
rates of substance use disorder have also been associated with high rates of interpersonal 
violence and injuries in the country (Norman et al, 2007; Schneider et al, 2007). A large 
percentage of patients visiting emergency departments in the country as a result of injuries 
are more likely to test positive for alcohol use (Parry et al, 2002; Plüddemann et al, 2003). In 
addition to these, substance use also inflicts financial burden on the economy. For instance, it 
has been reported that there are about 235,777 problem drug users costing the country 
approximately R10 billion; and about 1.97 million ‘problem drinkers’ and 3.2 million ‘risky 
drinkers’ (Central Drug Authority, 2011:p.1), also costing the country about R78 billion in 
direct costs and socio-economic cost of about R130 billion each year (Central Drug 
Authority, 2011).   
A number of interventions are available to help substance users and brief interventions have 
been found to be effective in reducing substance use and related problems, especially among 
moderate substance users who are not yet dependent on these substances. The effectiveness 





In the Western Cape Province of South Africa, Project STRIVE (Substance use and Trauma 
Intervention) assessed the effectiveness of two 
brief interventions, motivational interviewing 
and a combination of motivational interviewing 
with problem solving therapy in emergency 
departments. These interventions were 
administered by peer counsellors who were 
recruited from the communities and trained to 
offer these interventions. Patients classified as 
being at moderate and high risk after being 
screened with the ASSIST were randomised to 
receive either of the interventions. After three 
months follow-up they found that these 
interventions were more effective in reducing 
substance use represented by reduction in 
patient’s ASSIST score, verbal argument and 
depression.   
To assess the financial implication of providing 
these interventions and to -promote the efficient allocation of resources, a cost-effectiveness 
analysis was conducted. This analysed the costs of the interventions and compared with their 
effectiveness as found by Project STRIVE. 
Description of interventions offered by Project 
STRIVE 
v Motivational interviewing (MI) group:
patients in this group were offered 30
minutes motivational interview (patient-
centred counselling style), received
substance use risk-cards and fact sheets.
v Motivational interviewing (MI) with
Problem solving therapy (PST) group:
patients in this group were offered in
addition to motivational interviewing, 4
extra  PST sessions, received PST booklets
that contained assignments for them to do
at home and the substance use fact sheets.
The  PST was meant to help patients
developing problem solving and coping
skills
v Control group: these patients received
only the substance use fact sheet. During
the three months follow-up they were





The study assessed cost-effectiveness of the two interventions compared to a status-quo of no 
intervention. To know the cost of using peer counsellors instead of clinical psychologists, the 
cost of task-shifting was also analysed. 
Cost-effectiveness analysis: brief background information 
v Cost-effectiveness analysis compares the costs and effectiveness of alternative
interventions by generating incremental cost-effectiveness ratios (ICERs) of the
interventions which forms the basis for decision making between the interventions.
v ICER is the ratio of the incremental costs and effectiveness of the alternative
interventions. This is estimated by calculating the additional costs and effectiveness of
each of the interventions compared to the status-quo situation (in this situation a no
intervention situation). This is expressed as the additional cost per each additional
effect derived from the intervention.
v The intervention with the lowest ICER value is usually preferred over the one with the
higher ICER value. This is because a relatively lower additional cost needs to be
incurred to gain the additional effectiveness from the intervention compared to the
alternative intervention.
v Costs are analysed from either a provider, patient or societal perspective
• Provider’s perspective: these are costs incurred by the provider for the intervention
• Patient’s perspective: these are costs incurred by the patient (and their family and
friends) for receiving the intervention
• Societal perspective: this is the combination of the costs from both the provider


















The cost-effectiveness of introducing either of the interventions was calculated as the 
additional costs incurred for each additional reduction in patient’s ASSIST score, depressive 
symptoms and verbal argument compared to status-quo of no intervention. Costs were 
estimated from both the provider and the societal perspectives. Costs included in the analysis 
were the costs of screening, the overheads costs of emergency department visits and the 
direct costs of the interventions. Costs were estimated from both the provider and the societal 
perspectives.  
FINDINGS 
 The overall average cost per patient for MI with PST intervention was more costly 
than the MI only intervention. The direct cost of the MI with PST intervention was 
more than twice that of the MI only intervention. 
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MI with PST intervention was relatively more costly (with a higher incremental cost) 
but more effective in reducing patient’s ASSIST score and depression than the MI 
only intervention. It had higher incremental costs and effectiveness but lower 
incremental cost-effectiveness ratios. 
The MI only intervention was relatively less costly and more effective compared to 
the MI with PST intervention with respect to reduction in verbal argument. It 
therefore had lower incremental cost-effectiveness ratios.  
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It was also found that at relatively lower cost, it was possible to train peer counsellors 
to screen and offer brief interventions to substance users in emergency departments 
Table 1: Cost of using a peer counsellor for screening and brief interventions instead of a 
clinical psychologist (task-shifting) 
Total cost of task-shifting 
Cost item 
Cost per peer 
counsellor 
Cost for all 5 
counsellors 
Contribution to total 
cost 
Cost of peer counsellor’s training R 2 500 R 12 500 2.22% 
Cost of fidelity checks R 55 890 R 279 450 49.73% 
Salary paid to peer counsellors R 54 000 R 270 000 48.05% 
Total R 112 390 R 561 950 100% 
Given the high prevalence of substance use and related problems in South Africa, especially 
in the Western Cape Province, providing interventions for at risk substance users could be the 
right thing to do. However, these interventions should be cost-effective to ensure the efficient 
use of scarce health care resources.  The following policy recommendations have been made 





Screening and offering brief interventions for substance use in emergency 
departments can be cost-effective in minimizing substance use, depression and verbal 
arguments among substance users. For reduction in patient’s ASSIST score and 
depression, offering the MI with PST intervention and in some situations not offering 
any intervention at all could be more cost-effective than offering just the MI 
intervention. For reduction in verbal argument on the other hand, offering the MI only 
intervention will be more cost-effective than the combined intervention of MI and 
PST. Policy makers should however take into consideration their budgetary limitation 
as well as ethical issues when deciding on which intervention to implement and how it 
should be done 
Using peer counsellors trained to screen and offer the interventions in emergency 
departments can be relatively cheaper and efficient, especially in the situation where 
there are not enough mental health workers to undertake the task. 
It will also be more cost-effective to provide the intervention in areas where the 
prevalence of substance use is higher than where it is relatively lower. This can help 
to minimise cost of peer counsellor’s time per patient which formed a high percentage 
of the direct costs of the interventions. It will also help to attain more benefits from 
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Appendix 1: Informed Consent form and Baseline questionnaire used for the STRIVE 
study        
 
UNIVERSITY OF CAPE TOWN 
 
Department of Psychiatry and Mental Health 
J Block Groote 
 Schuur Hospital  
Observatory , Cape Town  
Tel: 021-4042137  
Fax: 021-4488158  
 
 
INFORMED CONSENT TO TAKE PART IN THE  
SUBSTANCE USE INTERVENTION 
 
 
Introduction: We are asking you to take part in a research study. The aim is to test whether an 
intervention to reduce substance use among adults at trauma units in the Western Cape is 
effective. This study is being run by the University of Cape Town, the Department of Health, The 
Department of Social Development, and the Premier’s Office.  You qualify for this study because you 
are a patient of the trauma centre and you screened positive for substance use.  We hope to find 450 
adults to be in this study. If you decide to take part in the study, you will be asked questions about and 
may attend sessions related to decreasing your substance use and improving your health.   
 
What We’re Asking of You: 
 
Today- We will ask you to answer a set of questions about your substance use, problem solving 
ability, mental health, and other behaviours. This will take about 20 minutes of your time.   We will 
also ask you for contact information so that we can stay in touch with you during the study. 
 
Some of you (selected by chance) will also spend 20 minutes with health counsellor discussing 
substance use.  
 
Once a Week for 3 Weeks-Some patients will be selected by chance to attend 3 follow-up sessions.  
These sessions will discuss issues related to improving your problem solving skills. If you are 
selected, you will need to be here for about 1 hour each time. We will give you a voucher of R50 for 
each of your visits.  We will ask you to attend 3 extra sessions in total.  
 
Three and 6 months later - Three and 6 months later,  all participants will get a call from our research 
assistant who will ask you  more questions about your substance use, mental health and other 
behaviours.  
 
Risks or Discomforts - There are some risks to taking part in this study.  Answering some of our 
questions may make you uncomfortable.  All project staff must sign confidentiality agreements stating 
that they will not reveal any information. However, we cannot rule out the possibility that someone 
might reveal information about you to people outside the study. Your decision to take part or not take 
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Benefits of Taking Part in The Study: If you take part in this study you may decrease your 
substance use and increase your quality of life.  You will also help us understand the best way to help 
patients who use substances in the Western Cape reduce their use.   
 
Being In The Study Is Voluntary And Confidential: Taking part in this study is completely up to 
you.  All your information will be used for research purposes only. We will keep your information 
private.  If you don’t want to be in the study, that is okay.  If you don’t want to answer a certain 
question or don’t want to be in a certain part of the study that is also okay. If you choose not to take 
part or if you drop out, it will not affect any benefits you may be getting. We will still give you 
referrals to any services you may need.   
 
Privacy: Anyone who is working with any of the information you give us has to sign an agreement 
not to share what you tell us.  Your answers will be given a special number instead of your name.  No 
one else will know these are your answers.  In research reports, your answers will always be grouped 
with other people’s answers or disguised to protect you from being recognized. All confidential data 
will be stored in double-locked file cabinets. The screener and consent forms will be destroyed after 
one year of the completion of study activities.  
 
Future Contact: In the future, we may contact you to see if you want to take part in more study 
activities or another study.  If we do that, we will tell you about that study and ask you to complete a 
separate consent form if you agree to participate. 
 
Who to Contact With Questions: If you have any questions about your rights as a participant, 
concerns or complaints, contact Dr. Katherine Sorsdahl, Katherine.sorsdahl@uct.ac.za or 082 055 
4676. 
 
Indicating Consent: Because we have given you a lot of information, please tell me in your own 
words what you understand us to be asking of you. In the box below, please put your initials if you 
agree to each of the following activities.  You do not give up any rights by initialling any of the lines.  
 
 Initials What We’re Asking of You 
1  I agree to take part in the study, which has been fully described to me.  I will answer 
questions today and to the best of my ability attend all the sessions.   
  Agree to provide contact information so researcher can keep in touch and remind me 
of future sessions  
2  I agree to come back for additional sessions, if chosen. 
3  I understand that in about 3 and 6 months I will be receiving phone calls 
 
 
Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in substance use 
intervention 
 
I declare that: 
 
• I have read or had read to me this information and consent form and it is written in a 
language with which I am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been adequately 
answered. 
• I understand that taking part in this study is voluntary and I have not been pressured to 
take part. I also understand that I do not give up any rights by signing below. 
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• I may choose to leave the study at any time and will not be penalised or prejudiced in any 
way. 
• I may be asked to leave the study before it has finished, if the researcher feels it is in my 
best interests, or if I do not follow the study plan, as agreed to. 
• I have received an unsigned copy of this form to keep. 
 
     Signed at (place) ......................…........……            on (date) …………....………..  
        Day/Month/Year 
 
       .......................................................................  .........................................................................  
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A. Demographic Information 
 
Name ___________________________      contact #: _________________________ 
 
Name and number of friend or relative who we call to get hold of you: 
_____________________________ 
 
1. How many children do you have? __________ 
 
2. Marital Status:                                                    
 Single (never been married)                                                                                                                         
 Married                                                                                                                                                
 Divorced                                                                                                                                                 
 Widowed                                                                                                                                         
 Other (please state: _______________)        
     
3. How much school did you finish? _________ (e.g. Standard 3/matric)  
 
4. Which of the following best describes your work situation now? 
 Employed full-time                                                                                                                                                 
 Employed part-time                                                                                                                                                
 Self-employed                                                                                                                                                         
 Student                                                                                                                                                                    
 Retired/pensioner                                                                                                                                                     
 Disabled                                                                                                                                                                 
 Unemployed 
 
5. Have you received treatment for substance use?   Yes   NO 
 
6. In the past three months how many times have you been in trouble with the police? ______ 
6b. In the past three months how many times was this related to substance use? _________ 
 
7. Have you ever been arrested or convicted?   Yes   NO  
7b. If yes describe: (was it substance use related) 
_________________________________________________________________ 
 
8. How many times in the past 3 months were you injured? __________ 
8b. How many times in the past 3 months were you injured as a result of your substance use?  
________         
8c. Thinking about the times you were injured, on how many occasions did you seek medical 
treatment? ____________ 
 
9. How many times in the last 3 months have you got in a physical fight? ________ 
9b. How many times was alcohol or drugs involved in these physical fights? ______ 
 
10. How many times in the last 3 months have you got in a verbal argument/fight? ______ 
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Injury Specific Questions 
 
11. Injury Severity: Triage Colour:  Red  Orange  Yellow  Green 
 
12. Nature of Injury:                                                  13. Mechanism of Injury: How was 
injury caused: 
 Fracture                                                     Traffic Accident   
Poisoning 
Sprain                                                         Assault                          
Firearm/Gun 
 Cut or open wound                                    Fall                       Other 
 Bruises, superficial would                         Blunt Force/ Object    Don’t 
know 
 Haematoma/swelling                                 Fire/hot fluid            
Drowning 
 Burning Cerebral conclusion                     Strangulation 
 Injury other organs                                    
 Other _______________ 
 
 
14. Where did you get injured? 
    House            School        Commercial area                                                                                                                                    
    Street/Road    Shebeen      Other __________ 
         





 Leisure Playing 
 Drinking 
 Socializing (family friends) 



















Were you a:                                                            
 Driver                                                                    
 Pedestrian                                                             
 Passenger in private car                                       
 Passenger in taxi                                                   
 Bicyclist                                                             
 Motorcyclist 
Was there another car involved:  
 Yes   NO 
Self-Inflicted: 
Precipitating factors: 
 Family conflicts                                          
 Physical problem/disease or 
pregnancy      
Psychological/psychiatric condition         
 Financial                                                   
 Death in family                                          
 Sexual or physical assault                          
 Other _______________                            































READ:  I am going to read a list of the ways you might have felt or behaved. I am then 
going to ask you how often you have felt this way during the past month. 
 
  NEVER 
Some or 
little of the 




(3 or 4 Days 
a week) 
Most of the 
time (5,6, 7 
Days a 
week) 
1. I am worried by things that usually don’t bother 
me.         
2. I do not feel like eating, my appetite is poor.         
3. I feel that I cannot stop being sad even with 
help from my family.         
4. I feel that I am just as good as other people.         
5. I have trouble keeping my mind on what I was 
doing.         
6. I feel depressed.         
7. I feel that everything I do is a bit of an effort.         
8. I feel hopeful about the future.         
9. I feel my life has been a failure.         
10. I feel fearful.         
11. My sleep is restless.         
12. I am happy.         
Assaults:  
Relationship of Victim to Assailant:              What was the reason: 
 Spouse/Partner        X partner                Fight Quarrel                                                                          
 Parents                            Robbery                                                                              
 Other relative            Sexual Assault                                                                                   
 Friends                   Drug-related                                                                                     
 Stranger                      Other crimes                                                                                                  
 Police           Gang-related                                                                                                             
 Other               Political                                                                                             
 Don’t know      Xenophobia 
Who started the fight?  You   Other person/person  (how many ____)                           
How did it start _________________________________________ 
 





D. Problem Solving Skills 
READ: I am going to read to you ways you might think, feel and act when faced with a problem in 
everyday living. A problem is something important in your life that bothers you a lot, but you don’t 
right away know how to make it better or stop it from bothering you so much. The problem could be 
something about yourself (thoughts, feelings, behaviour, health, appearance or relationships with 
other people (family, friends) or your environment and the things that you own. 
1. I feel afraid when I have an important problem to 
solve                                                     
2.  When making decisions, I do not think carefully 
about my many options 0            1              2              3             4 
3. I get nervous and unsure of myself when I have to 
make an important decision 0            1              2              3             4     
4. When my first efforts to solve a problem fail, I 
give up quickly because finding a solution is too 
difficult 
0            1              2              3             4     
5. Sometimes even difficult problems can have a way 
of moving my life forward in positive ways 0            1              2              3             4     
6. If I avoid problems, they will generally go away on 
their own 0            1              2              3             4     
7. When I can’t solve a problem, I get very frustrated 0            1              2              3             4     
8. If I am faced with a difficult problem, I probably 
will not be able to solve it on my own no matter how 
hard I try 
0            1              2              3             4     
9. Whenever I have a problem, I believe that it can be 
solved 0            1              2              3             4     
10. I try to do anything I can in order to avoid 
problems in my life 0            1              2              3             4     
11.Difficult problems make me very upset 0            1              2              3             4     
12. When I have a decision to make, I take the time 
to try to predict the positive and negative 
consequences of each possible option before I act 
0            1              2              3             4     
13. When problems occur in my life, I like to deal 
with them as soon as possible 0            1              2              3             4     
14. When I am trying to solve a problem I go with the 
first good idea that comes to mind, 0            1              2              3             4     
13. I talk less than usual.         
14. I feel lonely.         
15. People are unfriendly.         
16. I enjoy life.         
17. I cry.         
18. I feel sad.         
19. I feel that people don’t like me.         
20. I cannot get going in the morning.         
21. Are you afraid of your spouse/partner?     
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15. When I am faced with a difficult problem, I 
believe that I will be able to solve it on my own if I 
try hard enough 
0            1              2              3             4     
16. When I have a problem to solve, one of the first 
things I do is get as many facts about the problem as 
possible 
0            1              2              3             4     
17.When a problem happens in my life, I put off 
trying to solve it for as long as possible 0            1              2              3             4     
18. I spend more time avoiding my problems than 
solving them 0            1              2              3             4     
19. Before I try to solve a problem, I set a specific 
goal so that I know exactly what I want to 
accomplish 
0            1              2              3             4     
20. When I have a decision to make, I do not take the 
time to consider the pros and cons of each option 0            1              2              3             4     
21. After carrying out a solution to a problem, I try to 
evaluate as carefully as possible how much the 
situation has changed for the better 
0            1              2              3             4     
22. I put of solving problems until it is too late to do 
anything about them 0            1              2              3             4     
23. When I am trying to solve a problem, I think of as 
many options as possible until I cannot come up with 
any more ideas 
0            1              2              3             4     
24. When making decisions, I go with my “gut 
feeling” without thinking too much about the 
consequences of each option 
0            1              2              3             4     
25. I am too impulsive when it comes to making 
decisions 0            1              2              3             4     
 
 
READ:  Now I am going to read a number of statements. Each one describes a way that you 
might (or might not) feel about your drinking. For each statement, you will need to answer 
from 1 to 5, to indicate how much you agree or disagree with it right now.   
  No!  NO 
? 
Undecided Yes YES 
  
Strongly 
Disagree Disagree  or Unsure Agree 
Strongly 
Agree 
1. I really want to make changes in my 
drinking/drug use 1 2 3 4 5 
2. Sometimes I wonder if I am an alcoholic 
and/or drug addict 1 2 3 4 5 
3. If I don't change my drinking/drug use soon, 
my 1 2 3 4 5 
problems are going to get worse           
4. I have already started making some changes 1 2 3 4 5 
in my drinking/drug use           
5. I was drinking /doing drugs too much at one 
time, but 1 2 3 4 5 
 





IF YES TO BEING ASSAULTED BY SPOUSE/PARTNER/X OR BEING AFRAID OF 
PARTNER… ASK THESE QUESTIONS: 
 
500 Has a current or previous husband or boyfriend 
ever insulted you or made you feel bad about 
yourself? Did this happen many times, a few 
times, once or did it not happen?  
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 
501 Has a current or previous husband or boyfriend 
ever belittled or humiliated you in front of other 
people? Did this happen many times, a few 
times, once or did it not happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 
I've managed to change my drinking. 1 2 3 4 5 
6. Sometimes I wonder if my drinking/drug 
use is 1 2 3 4 5 
hurting other people. 1 2 3 4 5 
7. I am a problem drinker/drug user. 1 2 3 4 5 
8. I'm not just thinking about changing my 1 2 3 4 5 
drinking, I'm already doing something about it.           
9. I have already changed my drinking, and I 1 2 3 4 5 
am looking for ways to keep from slipping           
back to my old pattern.           
10. I have serious problems with drinking/drug 
use 1 2 3 4 5 
11. Sometimes I wonder if I am in control of 1 2 3 4 5 
my drinking.           
12. My drinking/drug use is causing a lot of 
harm 1 2 3 4 5 
13. I am actively doing things now to cut down 1 2 3 4 5 
or stop drinking.           
14. I want help to keep from going back to the 1 2 3 4 5 
drinking/drug problems that I had before.           
15. I know that I have a drinking problem 1 2 3 4 5 
16. There are times when I wonder if I 
drink/do drugs 1 2 3 4 5 
too much.           
17. I am an alcoholic/drug addict 1 2 3 4 5 
18. I am working hard to change my drinking 1 2 3 4 5 
19. I have made some changes in my 
drinking/drug use, and I want some help to 
keep from going back to the way I used to 
drink 1 2 3 4 5 
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502 Has a current or previous husband or boyfriend 
ever done things to scare or intimidate you on 
purpose for example by the way he looked at 
you, by yelling and smashing things? Did this 
happen many times, a few times, once or did it 
not happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 
503 Has a current or previous husband or boyfriend 
ever threatened to hurt you? Did this happen 
many times, a few times, once or did it not 
happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 






Men often fight with their girlfriends/wives and often these fights get physical. I am going to 
ask some questions about this because we want to learn more about what women experience in 
their lives. I want you to speak freely and remember that everything you say will be 
confidential. 
 
512 Has a current or previous husband or boyfriend 
ever slapped you or threw something at you 
which could hurt you? Did this happen many 
times, a few times, once or did it not happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 
513 Has a current or previous husband or boyfriend 
ever pushed or shoved you? Did this happen 
many times, a few times, once or did it not 
happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 
514 Has a current or previous husband or boyfriend 
ever hit you with a fist or with something else 
which could hurt you? Did this happen many 
times, a few times, once or did it not happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 
515 Has a current or previous husband or boyfriend 
ever kicked, dragged, beat, choke or burnt you? 
Did this happen many times, a few times, once 
or did it not happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 
516 Has a current or previous husband or boyfriend 
ever threatened to use or actually use a gun, 
knife or other weapon against you? Did this 
happen many times, a few times, once or did it 
not happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 









There are also other things which women experience that they sometimes do not talk 
about. I want you to speak freely and remember that everything you say will be 
confidential. 
 
539 Has a current or previous husband or boyfriend 
ever physically forced you to have sex when you 
did not want to? Did this happen many times, a 
few times, once or did it not happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 
 
 
540 Have you ever have sex with a current or 
previous husband or boyfriend when you did not 
want to because you were afraid of what he 
might do? Did this happen many times, a few 
times, once or did it not happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 
 
 
541 Has a current or previous husband or boyfriend 
ever forced you to do something sexual that you 
found degrading or humiliating? Did this happen 
many times, a few times, once or did it not 
happen? 
NEVER .................................... 1 
ONCE ....................................... 2 
FEW ......................................... 3 
MANY ..................................... 4 
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Appendix 2: Screening questionnaire used to screen patients for substance use in the 
STRIVE study 
 
UNIVERSITY OF CAPE TOWN 
 
Department of Psychiatry and Mental Health 
J Block Groote 
 Schuur Hospital  
Observatory , Cape Town  
Tel: 021-4042137  




1. Are you a male or female?   Male  Female       2.  How old are you?________                   
3. What is your race:  Black       Coloured      White     Indian/Asian                                                                                                                                                       
4.  Injury Severity on admission: Triage Colour:  Red  Orange  Yellow  Green 
5.  Intent of Injury:    
 Unintentional (accidental, RTA)                                                                                                                               
 Intentional (assault, violence)                                                                                                                                     
 Self-inflicted (suicide, attempted suicide)                                                                                                                      
 Other ____________________________                                                                                                                                                                                    
 
I am going to ask you some questions about your experience of using these substances across 
your lifetime and in the past three months. These substances can be smoked, swallowed, 
snorted, inhaled, injected or taken in the form of pills (show drug card).Some of the 
substances listed may be prescribed by a doctor (like amphetamines, sedatives, pain 
medications). For this interview, we will not record medications that are used as prescribed 
by your doctor. However, if you have taken such medications for reasons other than 
prescription, or taken them more frequently or at higher doses than prescribed, please let me 
know. While we are also interested in knowing about your use of various illicit drugs, please 
be assured that information on such use will be treated as strictly confidential 
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Question 1: In your life, which of the following substances have you used: 
 YES NO 
Tobacco   
Alcoholic Beverages (beer, wine etc)   
Cannabis (dagga, marijuana)   
Cocaine (rocks, coke, crack)   
Amphetamine Type Stimulants (Tik)   
Inhalants (nitrous glue, petrol)   
Sedatives or sleeping pills (Mandrax)   
Hallucinogens (LSC, acid, mushrooms, PCP, 
special K etc) 
  
Opiods (heroin, morphine, methadone, unga)   
 
Probe if all answers are negative: 
  “Not even when you were in school?” 
If "No" to all items, skip substance use 
questions. 
If "Yes" to any of these items, ask 
Question 2 for each substance ever used. 
 
Question 2: In the past three months, how often have you used the substances you 






































Tobacco 0 2 3 4 6 
Alcoholic Beverages (beer, wine etc) 0 2 3 4 6 
Cannabis (dagga, marijuana) 0 2 3 4 6 
Cocaine (rocks, coke, crack) 0 2 3 4 6 
Amphetamine Type Stimulants (Tik) 0 2 3 4 6 
Inhalants (nitrous glue, petrol) 0 2 3 4 6 
Sedatives or sleeping pills (Mandrax) 0 2 3 4 6 
Hallucinogens (LSC, acid, mushrooms, PCP, special K etc) 0 2 3 4 6 
Opiods (heroin, morphine, methadone, unga) 0 2 3 4 6 
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Question 4: During the past three months, how often has your use of substances led to 






































Tobacco 0 4 5 6 7 
Alcoholic Beverages (beer, wine etc) 0 4 5 6 7 
Cannabis (dagga, marijuana) 0 4 5 6 7 
Cocaine (rocks, coke, crack) 0 4 5 6 7 
Amphetamine Type Stimulants (Tik) 0 4 5 6 7 
Inhalants (nitrous glue, petrol) 0 4 5 6 7 
Sedatives or sleeping pills (Mandrax) 0 4 5 6 7 
Hallucinogens (LSC, acid, mushrooms, PCP, special K 
etc) 0 4 5 6 7 
Opiods (heroin, morphine, methadone, unga) 0 4 5 6 7 
 
Question 5: During the past three months, how often have you failed to do what was 






































Tobacco 0 5 6 7 8 
Alcoholic Beverages (beer, wine etc) 0 5 6 7 8 
Cannabis (dagga, marijuana) 0 5 6 7 8 
Cocaine (rocks, coke, crack) 0 5 6 7 8 
Amphetamine Type Stimulants (Tik) 0 5 6 7 8 
Inhalants (nitrous glue, petrol) 0 5 6 7 8 
Sedatives or sleeping pills (Mandrax) 0 5 6 7 8 
Hallucinogens (LSC, acid, mushrooms, PCP, special K 
etc) 0 5 6 7 8 
Opiods (heroin, morphine, methadone, unga) 0 5 6 7 8 
 
Ask Questions 6 & 7 for all substances ever used (i.e. those endorsed in Question 1) 
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Question 6: Has a friend or relative or anyone else ever expressed concern about your 








































Tobacco 0 6 3 
Alcoholic Beverages (beer, wine etc) 0 6 3 
Cannabis (dagga, marijuana) 0 6 3 
Cocaine (rocks, coke, crack) 0 6 3 
Amphetamine Type Stimulants (Tik) 0 6 3 
Inhalants (nitrous glue, petrol) 0 6 3 
Sedatives or sleeping pills (Mandrax) 0 6 3 
Hallucinogens (LSC, acid, mushrooms, PCP, special K 
etc) 0 6 3 
Opiods (heroin, morphine, methadone, unga) 0 6 3 
 









































Tobacco 0     6 3 
Alcoholic Beverages (beer, wine etc) 0 6 3 
Cannabis (dagga, marijuana) 0 6 3 
Cocaine (rocks, coke, crack) 0 6 3 
Amphetamine Type Stimulants (Tik) 0 6 3 
Inhalants (nitrous glue, petrol) 0 6 3 
Sedatives or sleeping pills (Mandrax) 0 6 3 
Hallucinogens (LSC, acid, mushrooms, PCP, 
special K etc) 0 6 3 
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Total Score Drug 1: ______         Total Score Drug 3: _____       Total Drug 5: _____                                                                                                      
Total Score Drug 2: ______         Total Score drug 4: _____        Total Drug 6: ______                                                                                                                
 
Willingness to Participate in Substance use Interventions: 
Would you be willing to participate in studies with interview content similar to the one that 
you just had with me?  Yes   Maybe   No 
 
Would you willing be to participate in interventions for substance use that include:  
10-20 minute session with a health counsellor face to face  Yes   Maybe   No 
Two sessions with a health counsellor (1 week a part)         Yes   Maybe   No 
Three sessions with a health counsellor (1 week apart)        Yes   Maybe   No 
Four sessions with a health counsellor (1 week apart)          Yes   Maybe   No 
 
NOTES FOR COUNSELLOR 
 
Does the patient meet inclusion criteria for participation?      Yes   No 
Does the patient want to participate in the research study?     Yes   No 
 

















































 0 2 1 
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Appendix 3: Follow-up questionnaire (MI and control groups) used for the STRIVE 
study  
 
UNIVERSITY OF CAPE TOWN 
 
Department of Psychiatry and Mental Health 
J Block Groote 
 Schuur Hospital  
Observatory , Cape Town  
Tel: 021-4042137  




6. In the past three months how many times have you been in trouble with the police? ______ 
6b. In the past three months how many times was this related to substance use? _________ 
 
8.   How many times in the past 3 months were you injured? __________ 
8b. How many times in the past 3 months were you injured as a result of your substance use?  
________         
8c. Thinking about the times you were injured, on how many occasions did you seek medical 
treatment? ____________ 
 
9. How many times in the last 3 months have you got in a physical fight? ________ 
9b. How many times was alcohol or drugs involved in these physical fights? ______ 
 
10. How many times in the last 3 months have you got in a verbal argument/fight? ______ 



























READ:  I am going to ask you some questions about your substance use in the past 3 months.   
 
Question 2: In the past three months, how often have you used the substances you 
mentioned (FIRST DRUG, SECOND DRUG, ETC) 
 
If "Never" to all items in Question 2, skip to Question 6. If any substances in Question 2 




Question 3: During the past three months, how often have you had a strong desire or 





































Tobacco 0 3 4 5 6 
Alcoholic Beverages (beer, wine etc) 0 3 4 5 6 
Cannabis (dagga, marijuana) 0 3 4 5 6 
Cocaine (rocks, coke, crack) 0 3 4 5 6 
Amphetamine Type Stimulants (Tik) 0 3 4 5 6 
Inhalants (nitrous glue, petrol) 0 3 4 5 6 
Sedatives or sleeping pills (Mandrax) 0 3 4 5 6 




































Tobacco 0 2 3 4 6 
Alcoholic Beverages (beer, wine etc) 0 2 3 4 6 
Cannabis (dagga, marijuana) 0 2 3 4 6 
Cocaine (rocks, coke, crack) 0 2 3 4 6 
Amphetamine Type Stimulants (Tik) 0 2 3 4 6 
Inhalants (nitrous glue, petrol) 0 2 3 4 6 
Sedatives or sleeping pills (Mandrax) 0 2 3 4 6 
Hallucinogens (LSC, acid, mushrooms, PCP, special K 
etc) 0 2 3 4 6 
Opiods (heroin, morphine, methadone, unga) 0 2 3 4 6 
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Opiods (heroin, morphine, methadone, unga) 0 3 4 5 6 
Question 4: During the past three months, how often has your use of substances led to 





































Tobacco 0 4 5 6 7 
Alcoholic Beverages (beer, wine etc) 0 4 5 6 7 
Cannabis (dagga, marijuana) 0 4 5 6 7 
Cocaine (rocks, coke, crack) 0 4 5 6 7 
Amphetamine Type Stimulants (Tik) 0 4 5 6 7 
Inhalants (nitrous glue, petrol) 0 4 5 6 7 
Sedatives or sleeping pills (Mandrax) 0 4 5 6 7 
Hallucinogens (LSC, acid, mushrooms, PCP, special K 
etc) 0 4 5 6 7 
Opiods (heroin, morphine, methadone, unga) 0 4 5 6 7 
 
 
Question 5: During the past three months, how often have you failed to do what was 











































Tobacco 0 5 6 7 8 
Alcoholic Beverages (beer, wine etc) 0 5 6 7 8 
Cannabis (dagga, marijuana) 0 5 6 7 8 
Cocaine (rocks, coke, crack) 0 5 6 7 8 
Amphetamine Type Stimulants (Tik) 0 5 6 7 8 
Inhalants (nitrous glue, petrol) 0 5 6 7 8 
Sedatives or sleeping pills (Mandrax) 0 5 6 7 8 
Hallucinogens (LSC, acid, mushrooms, PCP, special K 
etc) 0 5 6 7 8 
Opiods (heroin, morphine, methadone, unga) 0 5 6 7 8 
 
160 | P a g e  
 
Question 6: Has a friend or relative or anyone else ever expressed concern about your 








































Tobacco 0 6 3 
Alcoholic Beverages (beer, wine etc) 0 6 3 
Cannabis (dagga, marijuana) 0 6 3 
Cocaine (rocks, coke, crack) 0 6 3 
Amphetamine Type Stimulants (Tik) 0 6 3 
Inhalants (nitrous glue, petrol) 0 6 3 
Sedatives or sleeping pills (Mandrax) 0 6 3 
Hallucinogens (LSC, acid, mushrooms, PCP, special K 
etc) 0 6 3 
Opiods (heroin, morphine, methadone, unga) 0 6 3 
 
 









































Tobacco 0 6 3 
Alcoholic Beverages (beer, wine etc) 0 6 3 
Cannabis (dagga, marijuana) 0 6 3 
Cocaine (rocks, coke, crack) 0 6 3 
Amphetamine Type Stimulants (Tik) 0 6 3 
Inhalants (nitrous glue, petrol) 0 6 3 
Sedatives or sleeping pills (Mandrax) 0 6 3 
Hallucinogens (LSC, acid, mushrooms, PCP, 
special K etc) 0 6 3 









Total Score Drug 1: ______         Total Score Drug 3: _____       Total Drug 5: _____                                                                                                      






READ:  I am going to read a list of the ways you might have felt or behaved. I am then 
going to ask you how often you have felt this way during the past month. 








































 0 2 1 
















1. I am worried by things that usually 
don’t bother me.         
2. I do not feel like eating, my appetite is 
poor.         
3. I feel that I can not stop being sad even 
with help from my family.         
4. I feel that I am just as good as other 
people.         
5. I have trouble keeping my mind on what 
I was doing.         
6. I feel depressed.         
7. I feel that everything I do is a bit of an 
effort.         
8. I feel hopeful about the future.         
9. I feel my life has been a failure.         
10. I feel fearful.         
11. My sleep is restless.         
12. I am happy.         
13. I talk less than usual.         
14. I feel lonely.         
 





D. Problem Solving Skills 
READ: I am going to read to you ways you might think, feel and act when faced with a 
problem in everyday living. A problem is something important in your life that bothers you a 
lot, but you don’t right away know how to make it better or stop it from bothering you so 
much. The problem could be something about yourself (thoughts, feelings, behaviour, health, 
appearance or relationships with other people (family, friends) or your environment and the 
things that you own. 
 
1. I feel afraid when I have an important problem to 
solve                                                     
2.  When making decisions, I do not think carefully 
about my many options 0            1              2              3             4     
3. I get nervous and unsure of myself when I have 
to make an important decision 0            1              2              3             4     
4. When my first efforts to solve a problem fail, I 
give up quickly because finding a solution is too 
difficult 
0            1              2              3             4     
5. Sometimes even difficult problems can have a 
way of moving my life forward in positive ways 0            1              2              3             4     
6. If I avoid problems, they will generally go away 
on their own 0            1              2              3             4     
7. When I can’t solve a problem, I get very 
frustrated 0            1              2              3             4     
8. If I am faced with a difficult problem, I probably 
will not be able to solve it on my own no matter 
how hard I try 
0            1              2              3             4     
9. Whenever I have a problem, I believe that it can 
be solved 0            1              2              3             4     
10. I try to do anything I can in order to avoid 
problems in my life 0            1              2              3             4     
11.Difficult problems make me very upset 0            1              2              3             4     
12. When I have a decision to make, I take the time 
to try to predict the positive and negative 
consequences of each possible option before I act 
0            1              2              3             4     
13. When problems occur in my life, I like to deal 
with them as soon as possible 0            1              2              3             4     
14. When I am trying to solve a problem I go with 
the first good idea that comes to mind, 0            1              2              3             4     
15. People are unfriendly.         
16. I enjoy life.         
17. I cry.         
18. I feel sad.         
19. I feel that people don’t like me.         
20. I cannot get going in the morning.         
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15. When I am faced with a difficult problem, I 
believe that I will be able to solve it on my own if I 
try hard enough 
0            1              2              3             4     
16. When I have a problem to solve, one of the first 
things I do is get as many facts about the problem 
as possible 
0            1              2              3             4     
17.When a problem happens in my life, I put off 
trying to solve it for as long as possible 0            1              2              3             4     
18. I spend more time avoiding my problems than 
solving them 0            1              2              3             4     
19. Before I try to solve a problem, I set a specific 
goal so that I know exactly what I want to 
accomplish 
0            1              2              3             4     
20. When I have a decision to make, I do not take 
the time to consider the pros and cons of each 
option 
0            1              2              3             4     
21. After carrying out a solution to a problem, I try 
to evaluate as carefully as possible how much the 
situation has changed for the better 
0            1              2              3             4     
22. I put of solving problems until it is too late to 
do anything about them 0            1              2              3             4     
23. When I am trying to solve a problem, I think of 
as many options as possible until I cannot come up 
with any more ideas 
0            1              2              3             4     
24. When making decisions, I go with my “gut 
feeling” without thinking too much about the 
consequences of each option 
0            1              2              3             4     
25. I am too impulsive when it comes to making 




READ:  Now I am going to read a number of statements. Each one describes a way that you 
might (or might not) feel about your drinking. For each statement, you will need to answer 
from 1 to 5, to indicate how much you agree or disagree with it right now.   
  No!  NO 
? 
Undecided Yes YES 
  
Strongly 
Disagree Disagree  or Unsure Agree 
Strongly 
Agree 
1. I really want to make changes in my 
drinking/drug use 1 2 3 4 5 
2. Sometimes I wonder if I am an alcoholic 
and/or drug addict 1 2 3 4 5 
3. If I don't change my drinking/drug use 
soon, my 1 2 3 4 5 
problems are going to get worse           
4. I have already started making some 
changes in my drinking/drug use 1 2 3 4 5 
 












5. I was drinking /doing drugs too much at 
one time, but 1 2 3 4 5 
I've managed to change my drinking. 1 2 3 4 5 
6. Sometimes I wonder if my drinking/drug 
use is hurting other people 1 2 3 4 5 
7. I am a problem drinker/drug user. 1 2 3 4 5 
8. I'm not just thinking about changing my 1 2 3 4 5 
drinking, I'm already doing something about 
it.           
9. I have already changed my drinking, and 
I 1 2 3 4 5 
am looking for ways to keep from slipping           
back to my old pattern.           
10. I have serious problems with 
drinking/drug use 1 2 3 4 5 
11. Sometimes I wonder if I am in control of 1 2 3 4 5 
my drinking.           
12. My drinking/drug use is causing a lot of 
harm 1 2 3 4 5 
13. I am actively doing things now to cut 
down 1 2 3 4 5 
or stop drinking.           
14. I want help to keep from going back to 
the 1 2 3 4 5 
drinking/drug problems that I had before.           
15. I know that I have a drinking problem 1 2 3 4 5 
16. There are times when I wonder if I 
drink/do drugs 1 2 3 4 5 
too much.           
17. I am an alcoholic/drug addict 1 2 3 4 5 
18. I am working hard to change my 
drinking 1 2 3 4 5 
19. I have made some changes in my 
drinking/drug use, and I want some help to 
keep from going back to the way I used to 
drink 1 2 3 4 5 
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You may remember that three months ago you met with a health counsellor at the clinic 
who gave you feedback and information on your (insert drug name), and discussed with 
you the good and bad things about your drug use. You also attended sessions with the 
health counsellor to improve your problem solving skills. As mentioned when you met 
with (name of SW) three months ago, we would like to ask you what you honestly 
thought of the information and advice given to you by the health counsellors. 
 
1. How useful did you find the program in helping you to understand your level of risk? 
         Not Useful     Somewhat useful   Very Useful     Don’t know 
 
2. How useful did you find the program in helping you to understand the positive and 
negatives of using  (name drug/s)  
         Not Useful     Somewhat useful   Very Useful     Don’t know 
 
3. How useful did you find the program in helping you to understand what you can do 
about your use of  (name drug/s) 
         Not Useful     Somewhat useful   Very Useful     Don’t know 
 
4. How useful did you find the program in giving you tips and advice for helping you with 
your problems.  
         Not Useful     Somewhat useful   Very Useful     Don’t know 
 
5. How useful did you find the program in actually helping you to cut down or stop using 
(drug)  
         Not Useful     Somewhat useful   Very Useful     Don’t know 
 
  6.  How satisfied are you with the amount of help you received? 
        Quite satisfied                      Kind of satisfied           Mostly satisfied               
       Very satisfied 
  
7.  Have the services you received helped you to deal with your problems better 
        Yes they helped a great deal                          Yes they helped somewhat                                  
        No, they really didn’t help they really            No, they seemed to make things worse 
 
8. Would you have liked to have been offered more follow-up sessions with the counsellor? 
        Yes        Not sure        No 
Participant #: 
Participant Name:  
Follow-up date: 
Researcher:   
PST Group 
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9. Did the health counsellor refer you to a treatment centre for your substance use?   
 Yes     No 
 
9b. If yes, did you go and get help from the treatment centre?  Yes     No 
 








10a.  In the past three months how many times have you been in trouble with the police? 
______ 
10b.  In the past three months how many times was this related to substance use? _________ 
 
 11a. How many times in the past 3 months were you injured? __________ 
 11b. How many times in the past 3 months were you injured as a result of your substance   
          use?  ________         
 11c. Thinking about the times you were injured, on how many occasions did you seek   
         medical treatment?__ 
 
 12a.  How many times in the last 3 months have you got in a physical fight? ________ 
 12b. How many times was alcohol or drugs involved in these physical fights? ______ 
 
 13a. How many times in the last 3 months have you got in a verbal argument/fight? ______ 






1. How much did it cost to travel to the clinic for your PST session? _______ 
 
2. Did you have to take off work? If so, did you lose any payment? _______ 
 
3. Did you have to get someone to take care of your children when you went for your 
sessions? _________________________________________________ 
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READ:  I am going to ask you some questions about your substance use in the past 3 months.   
 
Question 2: In the past three months, how often have you used the substances you 
mentioned (FIRST DRUG, SECOND DRUG, ETC) 
 
If "Never" to all items in Question 2, skip to Question 6. If any substances in Question 2 




Question 3: During the past three months, how often have you had a strong desire or 






































Tobacco 0 3 4 5 6 
Alcoholic Beverages (beer, wine etc) 0 3 4 5 6 
Cannabis (dagga, marijuana) 0 3 4 5 6 
Cocaine (rocks, coke, crack) 0 3 4 5 6 
Amphetamine Type Stimulants (Tik) 0 3 4 5 6 
Inhalants (nitrous glue, petrol) 0 3 4 5 6 
Sedatives or sleeping pills (mandrax/buttons) 0 3 4 5 6 
Hallucinogens (LSC, acid, mushrooms, PCP, special K) 0 3 4 5 6 




































Tobacco 0 2 3 4 6 
Alcoholic Beverages (beer, wine etc) 0 2 3 4 6 
Cannabis (dagga, marijuana) 0 2 3 4 6 
Cocaine (rocks, coke, crack) 0 2 3 4 6 
Amphetamine Type Stimulants (Tik) 0 2 3 4 6 
Inhalants (nitrous glue, petrol) 0 2 3 4 6 
Sedatives or sleeping pills (mandrax/buttons) 0 2 3 4 6 
Hallucinogens (LSC, acid, mushrooms, PCP, special K) 0 2 3 4 6 
Opioids (heroin, morphine, methadone, unga) 0 2 3 4 6 
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Question 4: During the past three months, how often has your use of substances led to 





































Tobacco 0 4 5 6 7 
Alcoholic Beverages (beer, wine etc) 0 4 5 6 7 
Cannabis (dagga, marijuana) 0 4 5 6 7 
Cocaine (rocks, coke, crack) 0 4 5 6 7 
Amphetamine Type Stimulants (Tik) 0 4 5 6 7 
Inhalants (nitrous glue, petrol) 0 4 5 6 7 
Sedatives or sleeping pills (mandrax/buttons) 0 4 5 6 7 
Hallucinogens (LSC, acid, mushrooms, PCP, special K) 0 4 5 6 7 
Opioids (heroin, morphine, methadone, unga) 0 4 5 6 7 
 
 
Question 5: During the past three months, how often have you failed to do what was 





































Tobacco 0 5 6 7 8 
Alcoholic Beverages (beer, wine etc) 0 5 6 7 8 
Cannabis (dagga, marijuana) 0 5 6 7 8 
Cocaine (rocks, coke, crack) 0 5 6 7 8 
Amphetamine Type Stimulants (Tik) 0 5 6 7 8 
Inhalants (nitrous glue, petrol) 0 5 6 7 8 
Sedatives or sleeping pills (mandrax/buttons) 0 5 6 7 8 
Hallucinogens (LSC, acid, mushrooms, PCP, special K) 0 5 6 7 8 
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Question 6: Has a friend or relative or anyone else ever expressed concern about your 








































Tobacco 0 6 3 
Alcoholic Beverages (beer, wine etc) 0 6 3 
Cannabis (dagga, marijuana) 0 6 3 
Cocaine (rocks, coke, crack) 0 6 3 
Amphetamine Type Stimulants (Tik) 0 6 3 
Inhalants (nitrous glue, petrol) 0 6 3 
Sedatives or sleeping pills (mandrax/buttons) 0 6 3 
Hallucinogens (LSC, acid, mushrooms, PCP, special K) 0 6 3 
Opioids (heroin, morphine, methadone, unga) 0 6 3 
 
 









































Tobacco 0 6 3 
Alcoholic Beverages (beer, wine etc) 0 6 3 
Cannabis (dagga, marijuana) 0 6 3 
Cocaine (rocks, coke, crack) 0 6 3 
Amphetamine Type Stimulants (Tik) 0 6 3 
Inhalants (nitrous glue, petrol) 0 6 3 
Sedatives or sleeping pills (mandrax/buttons) 0 6 3 
Hallucinogens (LSC, acid, mushrooms, PCP, special K) 0 6 3 









Total Score Drug 1: ______         Total Score Drug 3: _____       Total Drug 5: _____                                                                                                      






READ:  I am going to read a list of the ways you might have felt or behaved. I am then 
going to ask you how often you have felt this way during the past month. 
 








































 0 2 1 
















1. I am worried by things that usually don’t bother 
me.         
2. I do not feel like eating, my appetite is poor.         
3. I feel that I cannot stop being sad even with help 
from my family.         
4. I feel that I am just as good as other people.         
5. I have trouble keeping my mind on what I was 
doing.         
6. I feel depressed.         
7. I feel that everything I do is a bit of an effort.         
8. I feel hopeful about the future.         
9. I feel my life has been a failure.         
10. I feel fearful.         
11. My sleep is restless.         
12. I am happy.         
13. I talk less than usual.         
14. I feel lonely.         
15. People are unfriendly.         
16. I enjoy life.         
 





D. Problem Solving Skills 
READ: I am going to read to you ways you might think, feel and act when faced with a problem in 
everyday living. A problem is something important in your life that bothers you a lot, but you don’t 
right away know how to make it better or stop it from bothering you so much. The problem could be 
something about yourself (thoughts, feelings, behaviour, health, appearance or relationships with 
other people (family, friends) or your environment and the things that you own. 
 
 
1. I feel afraid when I have an important problem to solve 0            1             2              3              4                                                        
2.  When making decisions, I do not think carefully about 
my many options 0            1             2              3              4     
3. I get nervous and unsure of myself when I have to make 
an important decision 0            1              2              3             4     
4. When my first efforts to solve a problem fail, I give up 
quickly because finding a solution is too difficult 0            1              2              3             4     
5. Sometimes even difficult problems can have a way of 
moving my life forward in positive ways 0            1              2              3             4     
6. If I avoid problems, they will generally go away on their 
own 0            1              2              3             4     
7. When I can’t solve a problem, I get very frustrated 0            1              2              3             4     
8. If I am faced with a difficult problem, I probably will not 
be able to solve it on my own no matter how hard I try 0            1              2              3             4     
9. Whenever I have a problem, I believe that it can be 
solved 0            1              2              3             4     
10. I try to do anything I can in order to avoid problems in 
my life 0            1              2              3             4     
11.Difficult problems make me very upset 0            1              2              3             4     
12. When I have a decision to make, I take the time to try 
to predict the positive and negative consequences of each 
possible option before I act 
0            1              2              3             4     
13. When problems occur in my life, I like to deal with 
them as soon as possible 0            1              2              3             4     
14. When I am trying to solve a problem I go with the first 
good idea that comes to mind 0            1              2              3             4     
15. When I am faced with a difficult problem, I believe that 
I will be able to solve it on my own if I try hard enough 0            1              2              3             4     
16. When I have a problem to solve, one of the first things I 
do is get as many facts about the problem as possible 0            1              2              3             4     
17.When a problem happens in my life, I put off trying to 
solve it for as long as possible 0            1              2              3             4     
18. I spend more time avoiding my problems than solving 
them 0            1              2              3             4     
19. Before I try to solve a problem, I set a specific goal so 
that I know exactly what I want to accomplish 0            1              2              3             4     
17. I cry.         
18. I feel sad.         
19. I feel that people don’t like me.         
20. I cannot get going in the morning.         
Not at all       Slightly       Moderately       Very true       Extremely 
True of me    true of me     true of me         true of me     true of me 
 
 
172 | P a g e  
 
20. When I have a decision to make, I do not take the time 
to consider the pros and cons of each option 0            1              2              3             4     
21. After carrying out a solution to a problem, I try to 
evaluate as carefully as possible how much the situation 
has changed for the better 
0            1              2              3             4     
22. I put of solving problems until it is too late to do 
anything about them 0            1              2              3             4     
23. When I am trying to solve a problem, I think of as 
many options as possible until I cannot come up with any 
more ideas 
0            1              2              3             4     
24. When making decisions, I go with my “gut feeling” 
without thinking too much about the consequences of each 
option 
0            1              2              3             4     
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Appendix 5: Project manager’s expenditure extraction sheet 
 
   Information on participants and materials used 
 














     
Number of MI 
participants 
     
Number of PST 
participants 
     
Number of controls      
 Khylitsha 
site B CHC 
KDH Elsie’s 
river 
Total for all 
facilities 




    
Control     
MI     
PST     
Tot. for 
study 
    
Number of 
STRIVE (single 
sheet or fact 
sheets) leaflets  
used 
Control     
MI     




risk cards  used   






PST     
Number of screeners 
(questionnaires for screening) 
used 
    
Number of pens used     
Number of clip boards used     
Number of other stationaries 
used (if any) 
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   Information on costs 





Cost of setting up and running the training (materials and 
other training equipment and cost of space if a room was 
rented for that) 
 
*Estimated cost of overseeing and administering training 
program (cost of trainer and other personnel if present to 
help or supervise the training) 
 
No. of days or hours of training( please separate time for MI 
and PST if possible) 
 
 
Cost of fidelity 
checks for 
counselors 
Cost of materials for such checks (if any) 
 
 
*Cost of personnel in charge of such checks   
Number of hours for such checks   
Cost of clinical psychologist. per hour or month (for the project)  
Salary of each counselor per month  
Salary of each supervisor for the counselors per month  
†Cost of employing a clinical psych. to administer the interventions per 
month 
 
Cost of screeners  
Cost of risk cards  
Cost of substance use information leaflets  
Cost of PST booklets  
 








    
 
N.B 
*If someone was hired to do the training (or checks in the case of fidelity chks), how much 
was paid for such a service. If the training was administered by regular worker in the 
department (e.g. yourself), what is his/her salary per day or hour. (If you can provide salary 
per month it will still be fine). This will help to work out the cost and opportunity cost of 
such trainings.  
†This is for the purpose of the analysis on task shifting. We are interested in estimating how 
much it will cost to employ a clinical psychologist to do the work of the counselors 
(screening and offering the interventions). 
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Appendix 7: Journal instructions for authors 
 
Cost Effectiveness and Resource Allocation 
Instructions for authors 
Research Articles 
 
Preparing main manuscript text 
General guidelines of the journal's style and language are given below. 
Overview of manuscript sections for Research Articles 
Manuscripts for Research Articles submitted to Cost Effectiveness and Resource Allocation 






Results and discussion 
Conclusions 
List of abbreviations used (if any) 
Competing interests 
Authors' contributions 




Illustrations and figures (if any) 
Tables and captions 
Preparing additional files 
The Accession Numbers of any nucleic acid sequences, protein sequences or atomic 
coordinates cited in the manuscript should be provided, in square brackets and include the 
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corresponding database name; for example, [EMBL:AB026295, EMBL:AC137000, 
DDBJ:AE000812, GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116]. 
The databases for which we can provide direct links are: EMBL Nucleotide Sequence 
Database (EMBL), DNA Data Bank of Japan (DDBJ), GenBank at the NCBI (GenBank), 
Protein Data Bank (PDB), Protein Information Resource (PIR) and the Swiss-Prot Protein 
Database (Swiss-Prot). 
You can download a template (Mac and Windows compatible; Microsoft Word 98/2000) for 
your article. 
For reporting standards please see the information in the About section.  
Title page 
The title page should:  
Provide the title of the article 
List the full names, institutional addresses and email addresses for all authors 
Indicate the corresponding author 
Please note: 
The title should include the study design, for example "A versus B in the treatment of C: a 
randomized controlled trial X is a risk factor for Y: a case control study" 
Abbreviations within the title should be avoided 
Abstract 
The Abstract of the manuscript should not exceed 350 words and must be structured into 
separate sections: Background, the context and purpose of the study; Methods, how the 
study was performed and statistical tests used; Results, the main findings; Conclusions, brief 
summary and potential implications. Please minimize the use of abbreviations and do not cite 
references in the abstract. Trial registration, if your research reports the results of a 
controlled health care intervention, please list your trial registry, along with the unique 
identifying number (e.g. Trial registration: Current Controlled Trials ISRCTN73824458). 
Please note that there should be no space between the letters and numbers of your trial 
registration number. We recommend manuscripts that report randomized controlled trials 
follow the CONSORT extension for abstracts. 
Keywords 
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Background  
The Background section should be written in a way that is accessible to researchers without 
specialist knowledge in that area and must clearly state - and, if helpful, illustrate - the 
background to the research and its aims. Reports of clinical research should, where 
appropriate, include a summary of a search of the literature to indicate why this study was 
necessary and what it aimed to contribute to the field. The section should end with a brief 
statement of what is being reported in the article. 
Methods  
The methods section should include the design of the study, the setting, the type of 
participants or materials involved, a clear description of all interventions and comparisons, 
and the type of analysis used, including a power calculation if appropriate. Generic drug 
names should generally be used. When proprietary brands are used in research, include the 
brand names in parentheses in the Methods section. 
For studies involving human participants a statement detailing ethical approval and consent 
should be included in the methods section. For further details of the journal's editorial 
policies and ethical guidelines see 'About this journal'. 
For further details of the journal's data-release policy, see the policy section in 'About this 
journal'. 
Results and discussion 
The Results and discussion may be combined into a single section or presented separately. 
Results of statistical analysis should include, where appropriate, relative and absolute risks or 
risk reductions, and confidence intervals. The Results and discussion sections may also be 
broken into subsections with short, informative headings. 
Conclusions 
This should state clearly the main conclusions of the research and give a clear explanation of 
their importance and relevance. Summary illustrations may be included. 
List of abbreviations 
If abbreviations are used in the text they should be defined in the text at first use, and a list of 
abbreviations can be provided, which should precede the competing interests and authors' 
contributions. 
Competing interests 
A competing interest exists when your interpretation of data or presentation of information 
may be influenced by your personal or financial relationship with other people or 
organizations. Authors must disclose any financial competing interests; they should also 
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reveal any non-financial competing interests that may cause them embarrassment were they 
to become public after the publication of the manuscript. 
Authors are required to complete a declaration of competing interests. All competing interests 
that are declared will be listed at the end of published articles. Where an author gives no 
competing interests, the listing will read 'The author(s) declare that they have no competing 
interests'. 
When completing your declaration, please consider the following questions: 
Financial competing interests 
In the past five years have you received reimbursements, fees, funding, or salary from an 
organization that may in any way gain or lose financially from the publication of this 
manuscript, either now or in the future? Is such an organization financing this manuscript 
(including the article-processing charge)? If so, please specify. 
Do you hold any stocks or shares in an organization that may in any way gain or lose 
financially from the publication of this manuscript, either now or in the future? If so, please 
specify. 
Do you hold or are you currently applying for any patents relating to the content of the 
manuscript? Have you received reimbursements, fees, funding, or salary from an organization 
that holds or has applied for patents relating to the content of the manuscript? If so, please 
specify. 
Do you have any other financial competing interests? If so, please specify. 
Non-financial competing interests  
Are there any non-financial competing interests (political, personal, religious, ideological, 
academic, intellectual, commercial or any other) to declare in relation to this manuscript? If 
so, please specify. 
If you are unsure as to whether you, or one your co-authors, has a competing interest please 
discuss it with the editorial office. 
Authors' contributions 
In order to give appropriate credit to each author of a paper, the individual contributions of 
authors to the manuscript should be specified in this section. 
An 'author' is generally considered to be someone who has made substantive intellectual 
contributions to a published study. To qualify as an author one should 1) have made 
substantial contributions to conception and design, or acquisition of data, or analysis and 
interpretation of data; 2) have been involved in drafting the manuscript or revising it critically 
for important intellectual content; and 3) have given final approval of the version to be 
published. Each author should have participated sufficiently in the work to take public 
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responsibility for appropriate portions of the content. Acquisition of funding, collection of 
data, or general supervision of the research group, alone, does not justify authorship.  
We suggest the following kind of format (please use initials to refer to each author's 
contribution): AB carried out the molecular genetic studies, participated in the sequence 
alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in 
the sequence alignment. ES participated in the design of the study and performed the 
statistical analysis. FG conceived of the study, and participated in its design and coordination 
and helped to draft the manuscript. All authors read and approved the final manuscript.  
All contributors who do not meet the criteria for authorship should be listed in an 
acknowledgements section. Examples of those who might be acknowledged include a person 
who provided purely technical help, writing assistance, or a department chair who provided 
only general support. 
Authors' information 
You may choose to use this section to include any relevant information about the author(s) 
that may aid the reader's interpretation of the article, and understand the standpoint of the 
author(s). This may include details about the authors' qualifications, current positions they 
hold at institutions or societies, or any other relevant background information. Please refer to 
authors using their initials. Note this section should not be used to describe any competing 
interests. 
Acknowledgements 
Please acknowledge anyone who contributed towards the article by making substantial 
contributions to conception, design, acquisition of data, or analysis and interpretation of data, 
or who was involved in drafting the manuscript or revising it critically for important 
intellectual content, but who does not meet the criteria for authorship. Please also include the 
source(s) of funding for each author, and for the manuscript preparation. Authors must 
describe the role of the funding body, if any, in design, in the collection, analysis, and 
interpretation of data; in the writing of the manuscript; and in the decision to submit the 
manuscript for publication. Please also acknowledge anyone who contributed materials 
essential for the study. If a language editor has made significant revision of the manuscript, 
we recommend that you acknowledge the editor by name, where possible.  
The role of a scientific (medical) writer must be included in the acknowledgements section, 
including their source(s) of funding. We suggest wording such as 'We thank Jane Doe who 
provided medical writing services on behalf of XYZ Pharmaceuticals Ltd.' 
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Endnotes 
Endnotes should be designated within the text using a superscript lowercase letter and all 
notes (along with their corresponding letter) should be included in the Endnotes section. 
Please format this section in a paragraph rather than a list. 
References 
All references, including URLs, must be numbered consecutively, in square brackets, in the 
order in which they are cited in the text, followed by any in tables or legends. Each reference 
must have an individual reference number. Please avoid excessive referencing. If automatic 
numbering systems are used, the reference numbers must be finalized and the bibliography 
must be fully formatted before submission. 
Only articles, datasets, clinical trial registration records and abstracts that have been 
published or are in press, or are available through public e-print/preprint servers, may be 
cited; unpublished abstracts, unpublished data and personal communications should not be 
included in the reference list, but may be included in the text and referred to as "unpublished 
observations" or "personal communications" giving the names of the involved researchers. 
Obtaining permission to quote personal communications and unpublished data from the cited 
colleagues is the responsibility of the author. Footnotes are not allowed, but endnotes are 
permitted. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference 
list should include all named authors, up to the first 30 before adding 'et al.'.. 
Any in press articles cited within the references and necessary for the reviewers' assessment 
of the manuscript should be made available if requested by the editorial office. 
Style files are available for use with popular bibliographic management software: 
BibTeX 
EndNote style file 
Reference Manager 
Zotero 
Examples of the Cost Effectiveness and Resource Allocation reference style are shown below. 
Please ensure that the reference style is followed precisely; if the references are not in the 
correct style they may have to be retyped and carefully proofread.  
All web links and URLs, including links to the authors' own websites, should be given a 
reference number and included in the reference list rather than within the text of the 
manuscript. They should be provided in full, including both the title of the site and the URL, 
in the following format: The Mouse Tumor Biology Database 
[http://tumor.informatics.jax.org/mtbwi/index.do]. If an author or group of authors can clearly 
be associated with a web link, such as for weblogs, then they should be included in the 
reference. 
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Examples of the Cost Effectiveness and Resource Allocation reference style 
 
Article within a journal 
Koonin EV, Altschul SF, Bork P: BRCA1 protein products: functional motifs. Nat Genet 
1996, 13:266-267. 
Article within a journal supplement 
Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I: Analysis and assessment of ab 
initio three-dimensional prediction, secondary structure, and contacts prediction. 
Proteins 1999, 43(Suppl 3):149-170. 
In press article 
Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J, in press. 
Published abstract 
Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN: Mesenchymal cells, 
stromal derived factor-1 and rheumatoid arthritis [abstract]. Arthritis Rheum 1999, 
42:s250. 
Article within conference proceedings 
Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First National 
Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: 
Butterworth-Heinemann; 1996:16-27. 
Book chapter, or article within a book 
Schnepf E: From prey via endosymbiont to plastids: comparative studies in 
dinoflagellates. In Origins of Plastids. Volume 2. 2nd edition. Edited by Lewin RA. New 
York: Chapman and Hall; 1993:53-76. 
Whole issue of journal 
Ponder B, Johnston S, Chodosh L (Eds): Innovative oncology. In Breast Cancer Res 1998, 
10:1-72. 
Whole conference proceedings 
Smith Y (Ed): Proceedings of the First National Conference on Porous Sieves: 27-30 June 
1996; Baltimore. Stoneham: Butterworth-Heinemann; 1996. 
Complete book 
Margulis L: Origin of Eukaryotic Cells. New Haven: Yale University Press; 1970. 
Monograph or book in a series 
Hunninghake GW, Gadek JE: The alveolar macrophage. In Cultured Human Cells and 
Tissues. Edited by Harris TJR. New York: Academic Press; 1995:54-56. [Stoner G (Series 
Editor): Methods and Perspectives in Cell Biology, vol 1.] 
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Book with institutional author 
Advisory Committee on Genetic Modification: Annual Report. London; 1999. 
PhD thesis 
Kohavi R: Wrappers for performance enhancement and oblivious decision graphs. PhD 
thesis. Stanford University, Computer Science Department; 1995. 
Link / URL 
The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/mtbwi/index.do] 
Link / URL with author(s) 
Corpas M: The Crowdfunding Genome Project: a personal genomics community with 
open source values [http://blogs.biomedcentral.com/bmcblog/2012/07/16/the-crowdfunding-
genome-project-a-personal-genomics-community-with-open-source-values/]  
Dataset with persistent identifier 
Zheng, L-Y; Guo, X-S; He, B; Sun, L-J; Peng, Y; Dong, S-S; Liu, T-F; Jiang, S; 
Ramachandran, S; Liu, C-M; Jing, H-C (2011): Genome data from sweet and grain 
sorghum (Sorghum bicolor). GigaScience. http://dx.doi.org/10.5524/100012. 
Clinical trial registration record with persistent identifier 
Mendelow, AD (2006): Surgical Trial in Lobar Intracerebral Haemorrhage. Current 
Controlled Trials. http://dx.doi.org/10.1186/ISRCTN22153967 
Preparing illustrations and figures 
Illustrations should be provided as separate files, not embedded in the text file. Each figure 
should include a single illustration and should fit on a single page in portrait format. If a 
figure consists of separate parts, it is important that a single composite illustration file be 
submitted which contains all parts of the figure. There is no charge for the use of color 
figures. 
Please read our figure preparation guidelines for detailed instructions on maximising the 
quality of your figures. 
Formats 
The following file formats can be accepted: 
PDF (preferred format for diagrams) 
DOCX/DOC (single page only) 
PPTX/PPT (single slide only) 
EPS 
PNG (preferred format for photos or images) 
TIFF 
 





The legends should be included in the main manuscript text file at the end of the document, 
rather than being a part of the figure file. For each figure, the following information should be 
provided: Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short 
title of figure (maximum 15 words); detailed legend, up to 300 words. 
Please note that it is the responsibility of the author(s) to obtain permission from the 
copyright holder to reproduce figures or tables that have previously been published 
elsewhere. 
Preparing tables 
Each table should be numbered and cited in sequence using Arabic numerals (i.e. Table 1, 2, 
3 etc.). Tables should also have a title (above the table) that summarizes the whole table; it 
should be no longer than 15 words. Detailed legends may then follow, but they should be 
concise. Tables should always be cited in text in consecutive numerical order. 
Smaller tables considered to be integral to the manuscript can be pasted into the end of the 
document text file, in A4 portrait or landscape format. These will be typeset and displayed in 
the final published form of the article. Such tables should be formatted using the 'Table 
object' in a word processing program to ensure that columns of data are kept aligned when 
the file is sent electronically for review; this will not always be the case if columns are 
generated by simply using tabs to separate text. Columns and rows of data should be made 
visibly distinct by ensuring that the borders of each cell display as black lines. Commas 
should not be used to indicate numerical values. Color and shading may not be used; parts of 
the table can be highlighted using symbols or bold text, the meaning of which should be 
explained in a table legend. Tables should not be embedded as figures or spreadsheet files. 
Larger datasets or tables too wide for a landscape page can be uploaded separately as 
additional files. Additional files will not be displayed in the final, laid-out PDF of the article, 
but a link will be provided to the files as supplied by the author. 
Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls ) or 
comma separated values (.csv). As with all files, please use the standard file extensions. 
Preparing additional files 
Although Cost Effectiveness and Resource Allocation does not restrict the length and quantity 
of data included in an article, we encourage authors to provide datasets, tables, movies, or 
other information as additional files. 
Please note: All Additional files will be published along with the article. Do not include files 
such as patient consent forms, certificates of language editing, or revised versions of the main 
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manuscript document with tracked changes. Such files should be sent by email to resource-
allocation@biomedcentral.com, quoting the Manuscript ID number. 
Results that would otherwise be indicated as "data not shown" can and should be included as 
additional files. Since many weblinks and URLs rapidly become broken, Cost Effectiveness 
and Resource Allocation requires that supporting data are included as additional files, or 
deposited in a recognized repository. Please do not link to data on a personal/departmental 
website. The maximum file size for additional files is 20 MB each, and files will be virus-
scanned on submission.  
Additional files can be in any format, and will be downloadable from the final published 
article as supplied by the author. We recommend CSV rather than PDF for tabular data. 
Certain supported files formats are recognized and can be displayed to the user in the 
browser. These include most movie formats (for users with the Quicktime plugin), mini-
websites prepared according to our guidelines, chemical structure files (MOL, PDB), 
geographic data files (KML).  
If additional material is provided, please list the following information in a separate section 
of the manuscript text: 
File name (e.g. Additional file 1) 
File format including the correct file extension for example .pdf, .xls, .txt, .pptx (including 
name and a URL of an appropriate viewer if format is unusual) 
Title of data 
Description of data 
Additional files should be named "Additional file 1" and so on and should be referenced 
explicitly by file name within the body of the article, e.g. 'An additional movie file shows this 
in more detail [see Additional file 1]'. 
Additional file formats 
Ideally, file formats for additional files should not be platform-specific, and should be 
viewable using free or widely available tools. The following are examples of suitable 
formats. 
Additional documentation  
PDF (Adode Acrobat) 
Animations  
SWF (Shockwave Flash) 
Movies  
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MP4 (MPEG 4) 
MOV (Quicktime) 
Tabular data  
XLS, XLSX (Excel Spreadsheet) 
CSV (Comma separated values) 
As with figure files, files should be given the standard file extensions. 
Mini-websites 
Small self-contained websites can be submitted as additional files, in such a way that they 
will be browsable from within the full text HTML version of the article. In order to do this, 
please follow these instructions: 
Create a folder containing a starting file called index.html (or index.htm) in the root. 
Put all files necessary for viewing the mini-website within the folder, or sub-folders. 
Ensure that all links are relative (ie "images/picture.jpg" rather than "/images/picture.jpg" or 
"http://yourdomain.net/images/picture.jpg" or "C:\Documents and Settings\username\My 
Documents\mini-website\images\picture.jpg") and no link is longer than 255 characters. 
Access the index.html file and browse around the mini-website, to ensure that the most 
commonly used browsers (Internet Explorer and Firefox) are able to view all parts of the 
mini-website without problems, it is ideal to check this on a different machine. 
Compress the folder into a ZIP, check the file size is under 20 MB, ensure that index.html is 
in the root of the ZIP, and that the file has .zip extension, then submit as an additional file 
with your article. 
Style and language 
General 
Currently, Cost Effectiveness and Resource Allocation can only accept manuscripts written in 
English. Spelling should be US English or British English, but not a mixture. 
There is no explicit limit on the length of articles submitted, but authors are encouraged to be 
concise.  
Cost Effectiveness and Resource Allocation will not edit submitted manuscripts for style or 
language; reviewers may advise rejection of a manuscript if it is compromised by 
grammatical errors. Authors are advised to write clearly and simply, and to have their article 
checked by colleagues before submission. In-house copyediting will be minimal. Non-native 
speakers of English may choose to make use of a copyediting service. 
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Help and advice on scientific writing 
The abstract is one of the most important parts of a manuscript. For guidance, please visit our 
page on Writing titles and abstracts for scientific articles. 
Tim Albert has produced for BioMed Central a list of tips for writing a scientific manuscript. 
American Scientist also provides a list of resources for science writing. For more detailed 
guidance on preparing a manuscript and writing in English, please visit the BioMed Central 
author academy. 
Abbreviations 
Abbreviations should be used as sparingly as possible. They should be defined when first 
used and a list of abbreviations can be provided following the main manuscript text. 
Typography 
Please use double line spacing. 
Type the text unjustified, without hyphenating words at line breaks. 
Use hard returns only to end headings and paragraphs, not to rearrange lines. 
Capitalize only the first word, and proper nouns, in the title. 
All pages should be numbered. 
Use the Cost Effectiveness and Resource Allocation reference format. 
Footnotes are not allowed, but endnotes are permitted. 
Please do not format the text in multiple columns. 
Greek and other special characters may be included. If you are unable to reproduce a 
particular special character, please type out the name of the symbol in full. Please ensure 
that all special characters used are embedded in the text, otherwise they will be lost 
during conversion to PDF. 
Units 
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Appendix 8: Plagiarism declaration 
Name: Dwommoh, Rebecca Akua Kyerewaa  
Student Number: DWMREB001  
Course: Master of Public Health (Health Economics) 
Declaration 
1. I know that plagiarism is wrong. Plagiarism is to use another’s work and pretend that
it is one’s own.
2. I have used the Harvard referencing convention for citation and referencing for the
protocol, literature review and policy brief and The Cost-effectiveness and Resource
Allocation reference style for the journal manuscript. Each contribution to, and
quotation in, this thesis from the work(s) of other people has been attributed, and has
been cited and referenced.
3. This thesis is my own work.
4. I have not allowed, and will not allow, anyone to copy my work with the intention of
passing it off as his or her own work.
Signature    
Date: 6th February, 2014 
